Nurses Revision

nursesrevision@gmail.com

Antineoplastic Agents

Antineoplastic Agents

ANTINEOPLASTIC AGENTS

Antineoplastic agents are a class of drugs designed to combat cancer by inhibiting the growth and proliferation of neoplastic cells (cancer cells). Also called Anticancer drugs.

The action of antineoplastic agents can be broadly categorized into two main mechanisms: affecting cell survival and enhancing the immune system’s ability to fight abnormal cells.

Common Terminology

  • Alopecia: Hair loss, a common side effect due to the drug’s action on rapidly dividing cells.
  • Angiogenesis: Formation of new blood vessels, which cancer cells induce to supply themselves with nutrients.
  • Carcinoma: A type of cancer that starts in epithelial cells.
  • Metastasis: The spread of cancer cells from the original site to other parts of the body.
  • Neoplasm: An abnormal growth of tissue, which can be benign or malignant (cancerous).
  • Sarcoma: A type of cancer that arises from connective tissues such as bone, muscle, and fat.
  • Anaplasia: loss of organization and structure; property of cancer cells.
  • Cancer: refers to a malignant neoplasm or new growth

Cancer can be divided into;

  1. Solid tumors
  2. Hematological

Solid Tumors; can further be differentiated into carcinomas, or tumors that originate in epithelial cells, and sarcomas, or tumors that originate in the mesenchyme and are made up of embryonic connective tissue cells.

Haematological Malignancies; involve blood forming organs of the body, the bone marrow, the lymphatic system. These malignancies alter the body’s ability to produce and regulate the cells found in the blood.

Classification of Antineoplastic Agents:

  1. Alkylating Agents: Interfere with DNA replication, most effective against slow-growing cancers.
  2. Antimetabolites: Resemble natural substances within the cell, disrupting DNA and RNA synthesis.
  3. Antineoplastic Antibiotics: Bind to DNA and prevent RNA synthesis, primarily affecting rapidly growing cells.
  4. Mitotic Inhibitors: Block cell division (mitosis), preventing the replication of cancer cells.
  5. Hormones and Hormone Modulators: Block or mimic hormones to inhibit the growth of hormone-sensitive tumors.
  6. Cancer Cell-Specific Agents: Target specific molecules involved in cancer cell growth and survival, minimizing damage to normal cells.
  7. Miscellaneous Antineoplastics: A diverse group with varying mechanisms of action, often used when other treatments are ineffective.
  1. Starts with G1 Phase: where the cell grows in size and releases enzymes for DNA replication. Cells may not progress hence remain at G0 phase.
  2. S Phase: Synthetic Phase: Where DNA replication occurs, cells make identical copies of their own chromosomes.
  3. G2 Phase: Check Point, When passed, they continue to grow and prepare themselves to divide.
  4. Mitosis Phase: where cell division occurs
  • Prophase: Chromosomes appear condensed and the nuclear envelope breaks down.
  • Metaphase: Where microtubules in the center align,
  • Anaphase: Chromosomes are separated
  • Telophase: 2 daughter cells formed
  • Cytokinesis: Either they become dormant(Gap 0) , or continue to G1 phase to create another cell division.
MITOSIS

Types of Antineoplastic Drugs

Alkylating Agents/DNA Replication Inhibitors

Alkylating agents work by adding an alkyl group to the DNA, thereby preventing the DNA strands from uncoiling and replicating. This is particularly effective in treating slow-growing cancers.

Indications:

  • Lymphomas
  • Leukemias
  • Myelomas
  • Ovarian, testicular, and breast cancers
  • Pancreatic cancer
  • Pulmonary carcinoma (lung cancer)
  • Rheumatoid arthritis

Contraindications:

  • Pregnancy and lactation (due to severe effects on the fetus and neonate)
  • Bone marrow suppression
  • Renal and hepatic dysfunction

Adverse Effects:

  • Gastrointestinal (GI): Nausea, vomiting, diarrhea, mucous membrane deterioration
  • Genitourinary (GU): Renal toxicity, increased uric acid levels
  • Hematological: Bone marrow suppression, leading to anemia, thrombocytopenia, and leukopenia
  • Alopecia

Examples of Alkylating Agents:

Drug

Indications

Dosage

Cyclophosphamide (Cytoxan, Neosar)

Lymphomas, Leukemias, Myelomas, Breast cancer

Induction: 40–50 mg/kg per day IV over 2–5 days; Maintenance: 1–5 mg/kg per day Orally/IV

Busulfan (Busulfex, Myleran)

Chronic myelogenous leukemia (CML), Lymphomas

Induction: 4–8 mg/d Orally; Maintenance: 1–3 mg/d Orally

Chlorambucil (Leukeran)

Hodgkin’s disease, Non-Hodgkin’s lymphoma

0.1–0.2 mg/kg per day Orally for 3–6 weeks; Maintenance: 0.03–0.1 mg/kg per day Orally

Antimetabolites

Antimetabolites mimic natural substances within the cell, interfering with DNA and RNA synthesis. These drugs are most effective against rapidly proliferating cells.

Indications:

  • Leukemias
  • Gastrointestinal cancers
  • Breast, stomach, pancreas, and colon cancer

Contraindications:

  • Pregnancy and lactation
  • Bone marrow suppression
  • Renal and hepatic dysfunction
  • GI ulceration

Adverse Effects:

  • CNS: Headache, drowsiness, dizziness
  • Respiratory: Pulmonary toxicity, interstitial pneumonitis
  • Hematological: Bone marrow suppression
  • GI: Nausea, vomiting, diarrhea, hepatic toxicity
  • GU: Renal toxicity

Examples of Antimetabolites:

Drug

Indications

Dosage

Methotrexate (Rheumatrex, Trexall)

Leukemias, Rheumatoid arthritis

15–30 mg Orally/IM depending on the disease being treated

Fluorouracil (Adrucil, Carac)

Breast, stomach, colon cancer

12 mg/kg per day IV on days 1–4, then 6 mg/kg IV on days 6, 8, 10, and 12

Antineoplastic Antibiotics

These drugs bind to DNA and inhibit RNA synthesis, primarily targeting rapidly dividing cells.

Indications:

  • Testicular cancer
  • Lymphomas
  • Squamous cell carcinoma
  • Choriocarcinoma

Contraindications:

  • Pregnancy and lactation
  • Bone marrow suppression
  • Renal and hepatic dysfunction
  • Pre-existing pulmonary or cardiac conditions

Adverse Effects:

  • CNS: Headache, drowsiness, dizziness
  • Respiratory: Pulmonary toxicity
  • Hematological: Bone marrow suppression
  • GI: Nausea, vomiting, hepatic toxicity
  • GU: Renal toxicity
  • Alopecia

Examples of Antineoplastic Antibiotics:

Drug

Indications

Dosage

Bleomycin (Blenoxane)

Testicular cancer, Lymphoma

Test dose of 1-2 units given 2-4 hours before therapy; 0.25–0.5 units/kg IM, IV, or SC once/twice weekly

Doxorubicin (Adriamycin, Doxil)

Breast cancer, Kaposi’s sarcoma

60–75 mg/m2 as a single IV dose; repeat every 21 days

 

Mitotic Inhibitors/Vinca Alkaloids

Mitotic inhibitors block cell division by inhibiting mitosis, specifically targeting the M phase of the cell cycle.

Indications:

  • Leukemia
  • Lymphomas (e.g., Hodgkin’s lymphoma)
  • Kaposi’s sarcoma
  • Testicular and breast cancer

Contraindications:

  • Pregnancy and lactation
  • Bone marrow suppression
  • Renal and hepatic dysfunction
  • GI ulceration

Adverse Effects:

  • CNS: Headache, drowsiness, dizziness
  • Hematological: Bone marrow suppression
  • GI: Nausea, vomiting, mucous membrane deterioration
  • GU: Renal toxicity
  • Alopecia
  • Neuropathy, stomatitis, constipation

Examples of Mitotic Inhibitors:

Drug

Indications

Dosage

Vincristine (Oncovin, Vincasar)

Leukemia, Lymphoma

Adult: 1.4 mg/m2 IV at weekly intervals

Vinblastine (Velban)

Hodgkin’s disease, Lymphoma

Adult: 3.7 mg/m2 IV once weekly; Pediatric: 2.5 mg/m2 IV once weekly

 

Hormones and Hormone Modulators

Some cancers, particularly those involving the breast tissue, ovaries, uterus, prostate, and testes, are sensitive to estrogen stimulation. Estrogen-receptor sites on the tumor react with circulating estrogen, and this reaction stimulates the tumor cells to grow and divide

Hormones and hormone modulators block or interfere with these receptor sites to prevent growth of the cancer and cause cell death.

Some hormones are used to block the release of gonadotropic hormones in breast or prostate cancer if the tumors are responsive to gonadotropic hormones. Others may block androgen-receptor sites directly.

Indications:

  • Breast cancer in postmenopausal women
  • Prostate cancer

Contraindications and Cautions

  1. Known allergy to drug: Prevent hypersensitivity reactions
  2. Hypercalcemia: Contraindication to the use of toremifene because the drug can increase serum calcium
  3. Pregnancy and lactation: Severe effects on the fetus and neonate
  4. Bone marrow suppression: Index of re-dosing and dosing levels
  5. Renal and hepatic dysfunction: Interfere with drug metabolism and excretion
  6. Known GI ulceration or ulcerative diseases: Can be exacerbated by the effects of the drug.

Adverse Effects:

  • Menopausal symptoms: Hot flashes, vaginal dryness, mood changes
  • Hematological: Bone marrow suppression
  • GI: Hepatic toxicity
  • GU: Renal toxicity
  • Hypercalcemia

Examples of Hormones and Hormone Modulators:

Drug

Indications

Dosage

Tamoxifen (Nolvadex)

Breast cancer

20–40 mg Orally per day

Anastrozole (Arimidex)

Breast cancer in postmenopausal women

1 mg Orally per day

Cancer Cell-Specific Agents

These drugs would not have the devastating effects on healthy cells in the body and would be more effective against particular cancer cells. Three groups of drugs are available for cancer cell–specific actions: protein tyrosine kinase inhibitors, an epidermal growth factor inhibitor, and a proteasome inhibitor.

Therapeutic Action

  1. Protein tyrosine kinase inhibitors act on specific enzymes that are needed for protein building by specific tumor Blocking of these enzymes inhibits tumor cell growth and division. They do not
    affect healthy human cells, so the patient does not experience
    the numerous adverse effects associated with antineoplastic
    chemotherapy. The protein tyrosine kinase inhibitors that are available include everolimus (Afinitor), gefitinib (Iressa), imatinib
    (Gleevec), lapatinib (Tykerb), nilotinib (Tasigna), sorafenib
    (Nexavar), sunitinib (Sutent), and temsirolimus (Torisel). 
  2. Epidermal growth factor inhibitors are drugs that act on epidermal growth factor receptors which are found in both normal and cancerous cells but are more abundant on rapidly
    growing cells. Example is erlotinib (Tarceva),
  3. Proteasome inhibitors are drugs indicated for inhibition of proteasome in human cells, a large protein complex that works to maintain cell homeostasis and protein production.
    Without it, the cell loses homeostasis and dies. This drug was
    shown to delay growth in selected tumors. Example is bortezomib (Velcade)

Indications

Cancer cell-specific agents are indicated for the following medical conditions:

  1. Imatinib, the first drug approved protein tyrosine kinase inhibitor, is given orally and is approved to treat chronic myelocytic leukemia (CML). It selectively inhibits the Bcr-Abl tyrosine kinase created by the Philadelphia chromosome abnormality in
  2. Bortezomib is used for the treatment of multiple myeloma in patients whose disease had progressed after two standard

Contraindications and Cautions

  1. Pregnancy: All drugs in this class is pregnancy category D.
  2. Women of childbearing age: Must be advised to use barrier contraceptives while taking these drugs.
  3. Lactation: Can enter breast milk and use is only justified if benefits outweigh the danger.
  4. Hepatic dysfunction: Increased risk of toxicity with imatinib.
  5. Nilotinib is contraindicated with patients who have
    or who are at risk for prolonged QT intervals (hypokalemia,
    hypomagnesia, or taking another drug that prolongs the QT
    interval) because it prolongs the QT interval, and sudden
    deaths could occur.
  6. Known allergy to the drug: Prevent hypersensitivity

Adverse Effects

Use of cancer cell-specific agents may result to these adverse effects:

  1. Imatinib: GI upset, muscle cramps, heart failure, fluid retention, skin Severe adverse effects of traditional antineoplastic therapy (severe bone marrow depression, alopecia, severe GI effects) do not occur.
  2. Gefitinib: potentially severe interstitial lung disease and various eye symptoms
  3. Pazopanib: some bone marrow depression, diarrhea, hypertension, and liver impairment, change in hair color
  4. Lapatinib: diarrhea, liver impairment, altered heart function
  5. Erlotinib and bortezomib: cardiovascular events, pulmonary toxicity
  6. Bortezomib: peripheral neuropathy, liver and kidney impairment

Platinum analogues/ miscellaneous anti-neoplastics

The mechanism of action of this unrelated group of drugs is not entirely clear.

Examples of miscellaneous anti-neoplastics include

  1. Cisplatin: 20—70 mg/m2 IV
  2. Carboplatin: 360 mg/m2 IV
  3. Hydroxyurea: 20—80 mg/kg PO (it belongs to a class known as substituted ureas)

Indications

  1. Testicular cancer
  2. Ovarian cancer
  3. Bladder cancer
  4. Sickle cell crisis prevention for Contra indications, side effects are the same.

Nursing Considerations

Here are important nursing considerations when administering antineoplastic agents:

Nursing Assessment

These are the important things the nurse should include in conducting assessment, history taking, and examination:

  1. Assess for the mentioned cautions and contraindications (e.g. drug allergies, hepatorenal impairment, bone marrow suppression, pregnancy and lactation, etc.) to prevent any complications.
  2. Perform a thorough physical assessment (other medications taken, orientation and reflexes, vital signs, bowel sounds, etc.) to establish baseline data before drug therapy begins, to determine effectiveness of therapy, and to evaluate for occurrence of any adverse effects associated with drug therapy.
  3. Monitor result of laboratory tests such as CBC with differential to identify possible bone marrow suppression and toxic drug effects and establish appropriate dosing for the drug; and liver and renal function tests to determine need for possible dose adjustment and identify toxic drug effects.

Antineoplastic Agents Read More »

Spinal Cord Compression

Spinal Cord Compression

Spinal Cord Compression (SCC)

Spinal cord compression (SCC) results from processes that compress or displace arterial, venous, and cerebrospinal fluid spaces, as well as the cord itself.

Spinal cord compression (SCC) refers to the mechanical or pathological compression of the spinal cord, resulting in the displacement or obstruction of arterial, venous, and cerebrospinal fluid spaces, as well as direct cord involvement

This compression can arise due to intrinsic or extrinsic causes, leading to varying degrees of neurological dysfunction.

Etiology of Spinal Cord Compression

Etiology of Spinal Cord Compression

SCC can result from multiple conditions, broadly categorized into traumatic, neoplastic, degenerative, inflammatory, infectious, vascular, or iatrogenic causes.

1. Traumatic Causes

Trauma is a leading cause of SCC, often resulting from accidents, falls, or sports injuries. The injury can lead to:

  • Vertebral fractures, commonly affecting the cervical spine.
  • Facet joint dislocation, which can lead to spinal instability and compression.
  • Complete transection of the spinal cord, resulting in irreversible neurological deficits.
  • Brown-Séquard syndrome, a condition caused by spinal hemisection, often due to penetrating injuries. This results in ipsilateral motor weakness and contralateral loss of pain and temperature sensation.

2. Neoplastic Causes

Tumors, whether benign or malignant, can lead to SCC. These include:

  • Primary spinal tumors (e.g., meningiomas, schwannomas, ependymomas).
  • Metastatic tumors, commonly from lung, breast, prostate, and renal cancers.
  • Hematologic malignancies such as lymphoma, multiple myeloma, and leukemia.
  • Paraneoplastic syndromes leading to acute myelopathy.
  • Meningeal carcinomatosis, in which cancer spreads to the meninges, causing extensive spinal cord involvement.

3. Degenerative Causes

Age-related degeneration of the spine can lead to compression via:

  • Intervertebral disc herniation, commonly at L4-L5 and L5-S1, potentially causing cauda equina syndrome.
  • Cervical disc herniation, which can result in myelopathy.
  • Cervical spondylotic myelopathy, a progressive condition due to osteophyte formation, disc herniation, and ligamentum flavum hypertrophy.

4. Vascular Causes

  • Epidural or subdural hematomas, typically occurring after trauma, spinal procedures, or in patients on anticoagulation therapy.
  • Spinal cord infarction, which may occur due to atherosclerosis, embolism, or systemic hypotension.
  • Arteriovenous malformations (AVMs), which can rupture and cause compression.

5. Inflammatory and Autoimmune Disorders

  • Rheumatoid arthritis (RA): Weakening of the ligamentous structures around the odontoid peg can result in atlantoaxial subluxation and high cervical cord compression.
  • Ankylosing spondylitis: Can cause severe kyphotic deformities leading to compression.
  • Multiple sclerosis (MS): Can lead to spinal cord demyelination and secondary compression.

6. Infectious Causes

  • Bacterial infections, such as vertebral osteomyelitis and discitis, can result in spinal cord compression.
  • Tuberculosis (Pott’s disease), a chronic infection that can cause vertebral collapse and epidural abscess formation.
  • Fungal infections, such as aspergillosis or cryptococcosis, are more common in immunocompromised patients.

7. Iatrogenic and Miscellaneous Causes

  • Complications from spinal surgery, including epidural fibrosis and post-operative hematomas.
  • Spinal manipulation: Though rare, chiropractic or osteopathic manipulation can lead to spinal injury.
  • Ossification of the posterior longitudinal ligament (OPLL): A condition seen in some Asian populations, leading to spinal canal narrowing.
Clinical Presentation of Spinal Cord Compression

Clinical Presentation of Spinal Cord Compression

The symptoms of SCC vary depending on the location, severity, and rate of onset.

Neurological Symptoms

  • Motor dysfunction: Progressive weakness, difficulty with fine motor tasks, clumsiness, and gait disturbances.
  • Sensory deficits: Loss of pain, temperature, proprioception, and vibration sensation, often in a dermatomal pattern.
  • Autonomic dysfunction: Loss of bladder, bowel, and sexual function.
  • Lhermitte’s sign: An electric shock-like sensation radiating down the spine and limbs upon neck flexion.

Neurological Signs

Upper motor neuron (UMN) signs (seen in spinal cord compression above the conus medullaris):

  • Hyperreflexia
  • Clonus
  • Spasticity
  • Positive Babinski sign (upgoing plantar reflex)

Lower motor neuron (LMN) signs (seen in cauda equina syndrome or nerve root compression):

  • Muscle atrophy
  • Hyporeflexia
  • Flaccid paralysis

Regional Effects of Compression

  • Cervical spine involvement: Can cause quadriplegia. Lesions at C3-C5 affect the phrenic nerve, leading to respiratory failure.
  • Thoracic spine involvement: Can cause paraplegia.
  • Lumbar spine involvement: Can affect the L4-S1 nerve roots, leading to radicular pain and cauda equina syndrome.

Autonomic Dysfunction

  • Neurogenic shock: Loss of sympathetic tone leading to hypotension and bradycardia.
  • Paralytic ileus: Gastrointestinal stasis due to autonomic dysfunction.
  • Urinary retention: Loss of bladder control, leading to overflow incontinence.
  • Priapism: A sustained, painful erection due to autonomic dysfunction.
  • Loss of thermoregulation: Impaired ability to control body temperature below the lesion level.

Diagnosis and Investigations

A thorough diagnostic workup is necessary to determine the underlying cause of SCC.

Laboratory Tests

  • Complete blood count (CBC): To assess for anemia, infection, or malignancy.
  • Inflammatory markers: ESR and CRP can be elevated in infections and inflammatory conditions.
  • Coagulation profile: Important if a hematoma is suspected.
  • Renal function and electrolytes: To assess for dehydration and metabolic abnormalities.

Imaging

  • MRI of the entire spine (gold standard): Provides detailed visualization of the spinal cord, nerve roots, and soft tissues.
  • CT scan with myelography: Useful when MRI is contraindicated (e.g., pacemakers, certain implants).
  • X-rays: Can detect fractures, vertebral instability, and degenerative changes.

Electrophysiological Studies

  • Somatosensory evoked potentials (SSEP): Can assess functional impairment of the spinal cord.
  • Electromyography (EMG) and nerve conduction studies (NCS): Useful in distinguishing SCC from peripheral neuropathy.

Management of Spinal Cord Compression (SCC)

Aims of Management

Effective management of spinal cord compression (SCC) requires a multidisciplinary approach aimed at;

  • stabilizing the spine, 
  • preserving neurological function, 
  • alleviating pain, and addressing the underlying cause. 

1. Immediate Management and Supportive Care

Spinal Stability and Nursing Care

  • Keep the patient flat with the spine in a neutral alignment using logrolling techniques or specialized turning beds. This prevents further injury until spinal and neurological stability are confirmed.
  • Use rigid cervical collars or spinal orthoses for immobilization in cases of suspected instability.

Corticosteroid Therapy

  • Dexamethasone is recommended to reduce spinal cord edema and inflammation.
  • A typical regimen includes a loading dose (e.g., 16 mg IV) followed by gradual tapering over days to weeks depending on the underlying condition.
  • Contraindications: Active infections, uncontrolled diabetes, gastrointestinal ulcers.

Management of Hemodynamic Instability

  • Postural hypotension should be managed with gradual position changes, compression garments (e.g., abdominal binders, elastic stockings), and devices to enhance venous return.
  • Avoid overhydration, as fluid overload can exacerbate pulmonary complications.

Bladder and Bowel Management

  • Urinary catheterization is often required for neurogenic bladder dysfunction to prevent urinary retention and infections.
  • Bowel management includes laxatives and scheduled bowel programs to prevent constipation or incontinence.

Respiratory Support

  • Patients with high cervical cord injuries (above C3-C5) may require mechanical ventilation due to diaphragm paralysis.
  • Breathing exercises, assisted coughing, suctioning, and chest physiotherapy help prevent aspiration pneumonia and secretion retention.

Psychosocial and Emotional Support

  • Patients may experience anxiety, depression, or distress due to functional limitations.
  • Counseling, psychiatric support, and spiritual care should be integrated into the treatment plan.

2. Pain Management

Pain control is essential for improving the patient’s quality of life and may involve a combination of pharmacologic and non-pharmacologic approaches.

Pharmacologic Pain Management

  • First-line therapy: NSAIDs, acetaminophen.
  • Moderate to severe pain: Opioids (e.g., morphine, oxycodone, fentanyl patches).
  • Neuropathic pain: Gabapentin, pregabalin, or tricyclic antidepressants (e.g., amitriptyline).
  • Bisphosphonates (e.g., zoledronic acid, pamidronate) for pain relief in cases of vertebral involvement from myeloma or metastatic breast/prostate cancer.
  • Corticosteroids also have analgesic effects, particularly in malignancy-related SCC.

Advanced Pain Control Strategies

For intractable pain, specialized pain procedures may be required:

  • Epidural analgesia or spinal nerve blocks.
  • Palliative radiotherapy for pain relief in metastatic SCC.
  • Vertebroplasty or kyphoplasty for vertebral compression fractures causing severe pain.

3. Definitive Treatment

Timing of Intervention

  • Early intervention is crucial—treatment should ideally begin before the patient loses ambulation or experiences severe neurological deterioration.
  • In malignant SCC, interventions should commence within 24 hours of diagnosis.

Surgical Intervention

Surgery is often indicated for mechanical instability, progressive neurological deficits, or refractory pain. Common procedures include:

  • Laminectomy (posterior decompression ± internal fixation).
  • Anterior cervical discectomy and fusion (ACDF) for cervical compression.
  • Vertebral corpectomy with spinal reconstruction in cases of extensive vertebral destruction.
  • Spinal stabilization using rods, screws, or cages to restore structural integrity.

Radiotherapy

  • Indicated in metastatic SCC or cases where surgery is contraindicated.
  • External beam radiotherapy (EBRT) is the most common modality.
  • Stereotactic body radiotherapy (SBRT) delivers precise high-dose radiation for certain tumors.

Chemotherapy and Targeted Therapy

  • Used in cases of hematologic malignancies (e.g., lymphoma, multiple myeloma).
  • Hormonal therapy for SCC due to hormone-sensitive cancers (e.g., prostate, breast cancer).

4. Discharge Planning and Rehabilitation

Recovery from SCC often requires long-term multidisciplinary rehabilitation to improve function and quality of life.

Comprehensive Discharge Planning

  • Assess home safety and support systems.
  • Train caregivers and family members in patient mobility, catheter care, and wound prevention.
  • Coordinate with community-based rehabilitation services.
  • Ensure follow-up appointments with neurologists, physiatrists, and oncologists (if applicable).

Physical Rehabilitation

  • Early mobilization and physiotherapy to prevent muscle atrophy and improve strength.
  • Assistive devices (wheelchairs, walkers, braces) as needed.
  • Occupational therapy to enhance daily functioning.

Psychological and Social Support

  • Coping mechanisms for disability adaptation.
  • Peer support groups for spinal cord injury (SCI) patients.

Cancer Screening and SCC Detection

Patients with known malignancies should undergo routine screening for SCC to ensure early detection.

Red Flags for Spinal Metastases in Cancer Patients

  • Persistent thoracic or cervical spine pain.
  • Progressive, unrelenting lumbar spinal pain.
  • Spinal pain exacerbated by movement, coughing, or straining.
  • Nocturnal spinal pain that disrupts sleep.
  • Localized spinal tenderness.

Symptoms Suggestive of Metastatic SCC

  • Radicular pain.
  • Limb weakness or gait disturbances.
  • Sensory loss or paresthesia.
  • Bladder or bowel dysfunction.
  • Neurological signs of cord or cauda equina compression.

Imaging Guidelines

MRI of the whole spine is the gold standard for diagnosis.

  • If spinal metastases are suspected: MRI within one week.
  • If SCC is suspected: MRI within 24 hours.
  • Urgent MRI (out of hours) for patients requiring emergency intervention.

Complications of SCC

  • Permanent paraplegia or quadriplegia.
  • Autonomic dysfunction (hypotension, neurogenic bladder).
  • Chronic neuropathic pain.
  • Pressure ulcers from prolonged immobility → Requires frequent repositioning.
  • Osteoporosis and fractures due to prolonged immobilization.
  • Aspiration pneumonia, atelectasis, ventilation-perfusion mismatch.
  • Acute respiratory distress syndrome (ARDS).
  • Depression and anxiety due to loss of independence.
  • Reduced participation in daily activities and social isolation.

Prognosis of SCC

  • Spinal cord regeneration is limited, so prognosis depends largely on the severity of the initial injury and timeliness of treatment.
  • Ambulatory status at the time of diagnosis is a key predictor of recovery—patients who are ambulatory at diagnosis have a significantly better prognosis.
  • Preventing complications (e.g., infections, pressure sores) is crucial for long-term outcomes.
  • Underlying etiology (e.g., trauma vs. malignancy) determines overall survival.

In cases of malignant SCC, prognosis depends on:

  • Primary tumor type and response to treatment.
  • Presence of metastases elsewhere.
  • Effectiveness of pain and symptom management.

Nursing care

  • Nurse the patient flat with the spine in neutral alignment (eg, using logrolling or turning beds) until spinal stability and neurological stability are ensured.
  • Give a course of dexamethasone unless contra-indicated until a definitive treatment plan is made.
  • Manage postural hypotension with positioning and devices to improve venous return; avoid overhydration.
  • Insert a catheter to manage bladder dysfunction.
  • Use breathing exercises, assisted coughing, and suctioning to clear airway secretions.
  • Offer and provide psychological and spiritual support as needed (including after discharge).
  • Analgesia, palliative radiotherapy, spinal orthoses, vertebroplasty or kyphoplasty, or spinal stabilization surgery may be required for pain control.
  • Bisphosphonates should be offered to all patients with vertebral involvement from myeloma and breast cancer and to patients with prostate cancer in whom conventional analgesia is inadequate.
  • Specialized pain control procedures may be needed for intractable pain (eg, epidural analgesia).
  • If definitive treatment of the cord compression is appropriate, it should be started before patients lose the ability to walk or before other neurological deterioration occurs, and ideally within 24 hours.
  • Definitive treatment may be using surgery (eg, laminectomy, posterior decompression ± internal fixation) or using radiotherapy.
  • Discharge should be fully planned and community-based rehabilitation and support should be available when the patient returns home. This includes support and any necessary training of carers and families.

Spinal Cord Compression Read More »

anticonvulsants

Anticonvulsants

Anticonvulsants

Anticonvulsants / antiepileptic drugs are a type of drugs that are used to prevent or treat seizures or convulsions by controlling abnormal electrical activity in the brain.

Common Terms

  • Absence seizure: type of generalized seizure that is characterized by sudden, temporary loss of consciousness, sometimes with staring or blinking for 3 to 5 seconds; formerly known as a petit mal seizure
  • Antiepileptic: drug used to treat the abnormal and excessive energy bursts in the brain that are characteristic of epilepsy.
  • Convulsion: tonic–clonic muscular reaction to excessive electrical energy arising from nerve cells in the brain.
  • Epilepsy: collection of various syndromes, all of which are characterized by seizures.
  • Generalized seizure: seizure that begins in one area of the brain and rapidly spreads throughout both hemispheres
  • Partial seizures: also called focal seizures; seizures involving one area of the brain that do not spread throughout the entire body.
  • Seizure: sudden discharge of excessive electrical energy from nerve cells in the brain
  • Status epilepticus: state in which seizures rapidly recur; most severe form of generalized seizure
  • Tonic–clonic seizure: type of generalized seizure that is characterized by serious clonic–tonic muscular reactions and loss of consciousness, with exhaustion and little memory of the event on awakening; formerly known as a grand mal seizure

A seizure is a sudden burst of uncontrolled electrical activity in the brain that occurs when neurons become excessively active.

Seizures can be generally classified into two major groups depending on where they begin in the brain;

  • Focal seizures affect initially only a portion of the brain typically one hemisphere and may occur with or without impairment of awareness.
  •  Generalized seizures affect both sides of the brain at the same time and almost always cause loss of consciousness.

 Seizures can be viewed as the result of an imbalance between inhibitory and excitatory processes in the brain that produces either too little inhibition or too much excitation. 

Inhibition and Excitation neurotransmitters.

  • Excitatory. Excitatory neurotransmitters “excite” the neuron and cause it to “fire off the message,” meaning, the message continues to be passed along to the next cell. Examples of excitatory neurotransmitters include glutamate, epinephrine and norepinephrine.
  • Inhibitory. Inhibitory neurotransmitters block or prevent the chemical message from being passed along any farther. Gamma-aminobutyric acid (GABA), glycine and serotonin are examples of inhibitory neurotransmitters.
  • Modulatory. Modulatory neurotransmitters influence the effects of other chemical messengers. They “tweak” or adjust how cells communicate at the synapse. They also affect a larger number of neurons at the same time.
anticonvulsant neurotransmitter

DRUGS FOR TREATING GENERALIZED SEIZURES

Hydantoins
  • Ethotoin
  • Fosphenytoin
  • Phenytoin
Barbiturates and Barbiturate-Like Drugs
  • Mephobarbital
  • Phenobarbital
  • Primidone
Benzodiazepines
  • Clonazepam
  • Diazepam
Succinimides
  • Ethosuximide
  • Methsuximide
Oxazolidinediones
  • Trimethdiaone
  • Paramethadione
Sulfonamides
  • Acetazolamide
  • Zonisamide
Valproates / Valproic Acid Derivatives.
  • Valproic acid
  • Sodium Valproate
  • Divalproex sodium

DRUGS FOR TREATING PARTIAL SEIZURES

Carboxamides
  • Carbamazepine
  • Oxcarbazepine
Gaba analogs
  • Pregabalin
  • Gabapentin
Triazines
  • Lamotrigine
Fructose derivatives
  • Topiramate

DRUGS FOR TREATING GENERALIZED SEIZURES

Drugs typically used to treat generalized seizures stabilize the nerve membranes by blocking channels in the cell membrane or altering receptor sites.

Because they work generally on the central nervous system (CNS), sedation and other CNS effects often result. Various drugs are used to treat generalized seizures, including hydantoins, barbiturates, barbiturate-like drugs, benzodiazepines, and succinimides. These drugs affect the entire brain and reduce the chance of sudden electrical
outburst.

Hydantoins

Hydantoins include ethotoin (Peganone), phenytoin (Dilantin). Because hydantoins are generally less sedating than many other antiepileptics, they may be the drugs of choice for patients who are not willing to
tolerate sedation and drowsiness. They do have significant adverse effects; thus, less toxic drugs, such as benzodiazepines, have replaced them in many situations. 

Indications of Hydantoins
  • Treatment of tonic–clonic and psychomotor seizures.
  • Short-term control of status epilepticus, prevention of seizures after neurosurgery.

Dose

Phenytoin

  • Adult: 100 mg Orally t.d.s., up to 300–400 mg/d; 10–15 mg/kg IV
  • Children: 5–8 mg/kg per day Orally; 5–10 mg/kg IV in divided doses
Contraindications of Hydantoins
  • Presence of allergy to any of these drugs to avoid hypersensitivity reactions.
  • Are associated with specific birth defects and should not be used in pregnancy or lactation unless the risk of seizures outweighs the potential risk to the fetus.
  • Women of childbearing age should be urged to use barrier contraceptives while taking these drugs.
Adverse effects
  • Nystagmus
  • ataxia
  • slurred speech
  • depression
  • confusion
  • drowsiness
  • lethargy
  • fatigue
  • constipation
  • dry mouth
  • anorexia
  • cardiac arrhythmias and changes in blood pressure
  • urinary retention
  • loss of libido.

Barbiturates and Barbiturate-Like Drugs

The barbiturates and barbiturate-type drugs inhibit impulse conduction in the ascending reticular activating system (RAS), depress the cerebral cortex, alter cerebellar function, and depress motor nerve output. They stabilize nerve membranes throughout the CNS directly by influencing ionic channels in the cell membrane, thereby decreasing excitability and hyperexcitability to stimulation.

Indications
  • Treatment of tonic–clonic and absence seizures.
  • Are also used as anxiolytic/hypnotic agent.
  • Emergency control of status epilepticus and acute seizures associated with eclampsia, tetanus, and other conditions.
  • Treatment of cortical focal seizures

Dose

Phenobarbital

  • Adult: 60–100 mg/d Orally; 200–320 mg IM or IV for acute episodes, may be repeated in 6 hours; reduce dose with elderly and with renal or hepatic impairment.
  • Children: 3–6 mg/kg per day Orally; 4–6 mg/kg per day IM or IV; 15–20 mg/kg IV over 10–15 min for status epilepticus.

Contraindications, Adverse effects, same as hydantoins

Benzodiazepines

The benzodiazepines may potentiate the effects of GABA, an inhibitory neurotransmitter that stabilizes nerve cell membranes. These drugs, which appear to act primarily in the limbic system and the RAS, also cause muscle relaxation and relieve anxiety without affecting cortical functioning substantially. The benzodiazepines stabilize nerve membranes throughout the CNS to decrease excitability and hyperexcitability to stimulation.

Indications
  • Treatment of absence and myoclonic seizures.
  • Treatment of severe convulsions, clonic–tonic seizures, status epilepticus; treatment of alcohol withdrawal and tetanus
  • Relieves tension, preoperative anxiety.
  • Administered to patients who do not respond to succinimides.
  • Being studied for use in the treatment of panic attacks, restless leg movements during sleep, hyperkinetic dysarthria(where you have difficulty speaking because the muscles you use for speech are weak), acute manic episodes, multifocal tic disorders, and neuralgias.

Dose

Diazepam

  • Adult: 2–10 mg Orally b.d. to q.i.d.; or 0.2 mg/kg PRN, may repeat in 4–12 h, 2–20 mg IM or IV
  • Geriatric or debilitated patients: 2–2.5 mg, Orally b.d.; or 2–5 mg IM or IV.
  • Pediatric: 1–2.5 mg Orally t.d.s to q.i.d.; or 0.3–0.5 mg/kg

Contraindications and adverse effects for benzodiazepines are the same as those
discussed for hydantoins.

DRUGS FOR TREATING PARTIAL SEIZURES

Partial seizures may be simple (involving only a single muscle or reaction) or complex (involving a series of reactions or emotional changes. Drugs used in the treatment of partial seizures include carbamazepine. Some of the drugs used to treat generalized seizures have also been found to be useful in treating partial seizures

The drugs used to control partial seizures stabilize nerve membranes in either of two ways—directly, by altering sodium and calcium channels, or indirectly, by increasing the activity of GABA, an inhibitory neurotransmitter, and thereby decreasing excessive activity.

Carbamazepine and oxcarbazepine are used as monotherapy, and the
remaining drugs are used as adjunctive therapy

Carbamazepine

Indications

  • Drug of choice for treatment of partial seizures and tonic–clonic seizures.
  • Treatment of trigeminal neuralgia, bipolar disorder.

Dose

  • Adult: 800–1200 mg/d Orally in divided doses 6–8 hourly.
  • Pediatric (> 12 yr): adult doses, do not exceed 1000 mg/d
  • Pediatric (6–12 yr): 20–30 mg/kg per day Orally in divided doses t.d.s to q.i.d.
  • Pediatric (<6 yr): 35 mg/kg per day Orally

Gabapentin

Indications

  • Used as adjunct in treating partial seizures
  • Treatment of postherpetic pain in adults and children ages 3–12 yr of age, migraines, bipolar disorders
  • Treatment of tremors of multiple sclerosis, and nerve-generated
    pain states

Dose

  • Adult: 900–1800 mg/d Orally in divided doses t.d.s
  • Pediatric (3–12 yr): 10–15 mg/kg per day Orally in divided doses.
Contraindications

Contraindications to the drugs used to control partial seizures include the following conditions:

  • presence of any known allergy to the drug
  • bone marrow suppression, which could be exacerbated by the drug effects
  • severe hepatic dysfunction, which could be exacerbated and could interfere with the metabolism of the drugs.
  • Pregnancy; Carbamazepine, clorazepate, gabapentin, and oxcarbazine have been shown to be dangerous to a fetus and should not be used during pregnancy. Women of childbearing age should be advised to use contraception.
  • Lactation; These drugs enter breast milk and can cause serious adverse effects in the baby. If any of these drugs is needed during lactation, another method of feeding the baby should be used.
Adverse Effects
  • drowsiness
  • fatigue
  • weakness
  • confusion
  • headache
  • insomnia
  • GI depression, with nausea, vomiting, and anorexia
  • upper respiratory infections.
  • can also be directly toxic to the liver and the bone marrow, causing dysfunction.

Nursing Considerations for Patients Receiving Anticonvulsants.

  1. Assess for contraindications and cautions: any known allergies to these drugs to avoid hypersensitivity reactions,
  2. Assess for history of bone marrow suppression or renal stones, which could be exacerbated by these drugs
  3. History of renal or hepatic dysfunction that might interfere with drug metabolism and excretion.
  4. Assess for current status of pregnancy or lactation, which are contraindicated or require caution when using these drugs.
  5. Inspect the skin for color and lesions to determine evidence of possible skin effects;
  6. Assess pulse and blood pressure and auscultate heart to evaluate for possible cardiac effects;
  7. Assess level of orientation, affect, reflexes, and bilateral grip strength to evaluate any CNS effects;
  8. Monitor bowel sounds and urine output to determine possible gastrointestinal or genitourinary effects.
  9. Assess the patient’s renal and liver function, including renal and liver function tests, to determine the appropriateness of therapy and determine the need for possible dose adjustment.
  10. Monitor the results of laboratory tests such as urinalysis and CBC with differential to identify changes in bone marrow function.

Nursing Diagnoses
Nursing diagnoses related to drug therapy might include the following:

  •  Acute Pain related to GI and CNS effects
  •  Disturbed Thought Processes related to CNS effects
  •  Risk for Injury related to CNS effects
  •  Risk for Infection related to bone marrow suppression effects
  •  Deficient Knowledge regarding drug therapy

Implementation With Rationale

  1.  Administer the drug with food to alleviate GI irritation if GI upset is a problem.
  2.  Monitor CBC before and periodically during therapy to detect and prevent serious bone marrow suppression.
  3.  Protect the patient from exposure to infection if bone marrow suppression occurs.
  4.  Discontinue the drug if skin rash, bone marrow suppression, unusual depression, or personality changes occur to prevent further serious adverse effects.
  5.  Discontinue the drug slowly, and never withdraw the drug quickly, because rapid withdrawal may precipitate seizures.
  6.  Arrange for counseling for women of childbearing age who are taking these drugs. Because these drugs have the potential to cause serious damage to the fetus, women should understand the risk of birth defects and use barrier contraceptives to avoid pregnancy
  7. Provide safety measures to protect the patient from injury or falls if CNS changes occur.
  8.  Provide patient teaching, including drug name and prescribed dosage, as well as measures for avoidance of adverse effects, warning signs that may indicate possible problems, and the need for periodic laboratory testing and monitoring and evaluation to enhance patient knowledge about drug therapy and to promote
    compliance.

Evaluation

  1.  Monitor patient response to the drug (decrease in incidence or absence of seizures).
  2.  Monitor for adverse effects (CNS changes, GI depression, bone marrow suppression, severe dermatological reactions,
    liver toxicity, renal stones).
  3.  Evaluate the effectiveness of the teaching plan (patient can give the drug name and dosage and name possible adverse effects to watch for and specific measures to prevent them; patient is aware of the risk of birth defects and the need to carry information about the diagnosis and use of this drug).
  4. Patients being treated with antiepileptic are often on long term therapy, which requires compliance with their drug regimen and restrictions associated with their disorder and the drug effects. Educate the patients about this.

MULTIPLE CHOICE QUESTIONS

Select the best answer to the following.

  1.  When teaching a group of students about epilepsy, which of the following should the nurse include?
    a. Always characterized by grand mal seizures.
    b. Only a genetic problem.
    c. The most prevalent neurological disorder.
    d. The name given to one brain disorder.
  2.  Which of the following would the nurse be least likely to include as a type of generalized seizure?
    a. Petit mal seizures.
    b. Febrile seizures.
    c. Grand mal seizures.
    d. Complex seizures.
  3.  Which instruction would the nurse encourage a patient receiving an antiepileptic drug to do?
    a. Give up his or her driver’s license.
    b. Carry a Medical form identification.
    c. Take antihistamines to help dry up secretions.
    d. Keep the diagnosis a secret to avoid prejudice.
  4.  Drugs that are commonly used to treat grand mal seizures include;
    a. barbiturates, benzodiazepines, and hydantoins.
    b. barbiturates, antihistamines, and local anesthetics.
    c. hydantoins, phenobarbital, and phensuximide.
    d. benzodiazepines, phensuximide, and valproic acid.
  5.  The drug of choice for the treatment of partial seizures is
    a. valproic acid.
    b. methsuximide.
    c. carbamazepine.
    d. ethosuximide.
  6.  Focal or partial seizures
    a. start at one point and spread quickly throughout the brain.
    b. are best treated with benzodiazepines.
    c. involve only part of the brain.
    d. are easily diagnosed and recognized.
  7.  One drug that is used alone in the treatment of partial seizures is
    a. carbamazepine.
    b. topiramate.
    c. lamotrigine.
    d. gabapentin.
  8.  Treatment of epilepsy is directed at
    a. blocking the transmission of nerve impulses into the
    brain.
    b. stabilizing overexcited nerve membranes
    c. blocking peripheral nerve terminals.
    d. thickening the meninges to dampen brain electrical activity.

Anticonvulsants Read More »

epilepsy

Epilepsy

Epilepsy Lecture Notes
Epilepsy

A seizure is an occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain. Epilepsy, however, is a chronic disorder characterized by recurrent, unprovoked seizures.

Epilepsy is a neurological disorder in which the brain activity becomes abnormal, causing seizures or periods of unusual behaviour, sensations, and sometimes loss of awareness.

The modern definition, established by the International League Against Epilepsy (ILAE), provides clear criteria for diagnosis.

Epilepsy Definition (ILAE)

Epilepsy is defined by the International League Against Epilepsy (ILAE) as a disease of the brain defined by any of the following conditions:

  1. At least two unprovoked (or reflex) seizures occurring more than 24 hours apart.
    • Unprovoked Seizures: These are seizures that occur without any immediate identifiable cause. This differentiates them from "provoked" seizures, which are acute symptomatic seizures triggered by a temporary or reversible systemic or brain insult (e.g., severe electrolyte imbalance, acute stroke, drug intoxication/withdrawal, high fever in children). A single provoked seizure does not typically lead to a diagnosis of epilepsy.
    • Reflex Seizures: These are seizures reliably induced by a specific afferent stimulus or specific cognitive activity (e.g., photosensitive epilepsy where seizures are triggered by flashing lights). While provoked, if they recur, they fall under the definition of epilepsy.
  2. One unprovoked (or reflex) seizure and a probability of further seizures similar to the general recurrence risk (at least 60%) after two unprovoked seizures, occurring over the next 10 years.
    • This criterion acknowledges that some individuals, after a single unprovoked seizure, have underlying conditions (e.g., an epileptogenic lesion on MRI, certain abnormal EEG findings) that confer a high risk of recurrence, essentially making the epilepsy diagnosis certain even after one event. Examples include:
      • An individual with a clear structural lesion in the brain (e.g., old stroke, tumor, malformation).
      • Specific epileptiform abnormalities on EEG.
      • Certain genetic syndromes.
Differentiating Epilepsy from a Single Seizure:
  • Single Seizure: A person can have one seizure without having epilepsy. This could be a provoked seizure (e.g., due to acute illness, drug overdose, high fever) or a single unprovoked seizure where the risk of recurrence is low (less than 60%). Many individuals will never have another seizure after a first unprovoked event.
  • Epilepsy: Implies a predisposition to generate seizures due to an underlying chronic brain disorder, requiring ongoing management.
Resolution of Epilepsy:

The ILAE also provides criteria for when epilepsy can be considered "resolved" for practical clinical and epidemiological purposes:

  • Individuals who have been seizure-free for 10 years, with no anti-seizure medication for the last 5 years.
  • Individuals who have reached the age-dependent remission criteria for an epilepsy syndrome that is known to resolve with age (e.g., benign epilepsy with centrotemporal spikes, childhood absence epilepsy).
Etiology of Epilepsy (The Cause)

The cause of epilepsy can be identified in many cases, though for some, the cause remains unknown. The International League Against Epilepsy (ILAE) classifies the etiologies of epilepsy into six main categories:

  1. Structural: Epilepsy caused by a visible abnormality in the brain structure. These abnormalities can be seen on imaging scans (like MRI).
    • Examples:
      • Brain tumors: Abnormal growths in the brain.
      • Stroke: Damage to the brain due to interruption of its blood supply.
      • Traumatic Brain Injury (TBI): Head trauma from accidents, falls, domestic violence, or other impacts. This includes both acute injury and the resulting scar tissue.
      • Brain malformations: Abnormal development of the brain before birth (e.g., cortical dysplasia).
      • Scar tissue: Specifically, scar tissue in areas like the temporal lobe (often from previous injury, infection, or stroke) can create an epileptic focus.
      • Prior hypoxia/anoxia: Brain damage due to lack of oxygen (e.g., at birth, or from other medical events).
  2. Genetic: Epilepsy caused by a known or presumed genetic mutation. These can be inherited or occur spontaneously.
    • Examples:
      • Familial epilepsy: Conditions that clearly run in families, suggesting an inherited genetic predisposition.
      • Specific genetic syndromes: Many syndromes are now known to involve epilepsy as a symptom.
  3. Infectious: Epilepsy resulting from a central nervous system (CNS) infection that causes brain inflammation or damage.
    • Examples:
      • Meningitis: Inflammation of the membranes surrounding the brain and spinal cord.
      • Encephalitis: Inflammation of the brain itself.
      • AIDS/HIV: The virus or opportunistic infections associated with it can damage the brain.
      • Neurocysticercosis: Parasitic infection affecting the brain.
  4. Metabolic: Epilepsy due to an underlying metabolic disorder that disrupts the brain's normal chemical balance and function.
    • Examples:
      • Inborn errors of metabolism: Genetic disorders that affect the body's ability to process nutrients (e.g., Phenylketonuria, mitochondrial disorders).
      • Electrolyte imbalances: Severe disturbances in sodium, calcium, magnesium levels.
      • Hypoglycemia/Hyperglycemia: Critically low or high blood sugar levels.
  5. Immune: Epilepsy caused by an autoimmune process where the body's immune system mistakenly attacks healthy brain cells.
    • Examples:
      • Autoimmune encephalitis: Inflammation of the brain caused by antibodies attacking brain proteins (e.g., anti-LGI1, anti-NMDA receptor encephalitis).
      • Systemic autoimmune diseases: Lupus, celiac disease, etc., can sometimes be associated with epilepsy.
  6. Unknown: When, despite thorough investigation, the cause of the epilepsy cannot be identified. This category applies when there's insufficient evidence to place it in one of the other categories.
Major Types of Epilepsy and Seizures

Epilepsy and seizures are broadly categorized based on where the seizure activity begins in the brain. Here, we'll explore some common types, including generalized seizures (affecting both sides of the brain) and focal seizures (starting in one area).

1. Generalized Tonic-Clonic Seizures (Formerly "Grand Mal Epilepsy")

Generalized tonic-clonic seizures are a major form of epilepsy characterized by a total loss of consciousness and a dramatic, convulsive event. These seizures typically last between 3 to 5 minutes. Following the seizure, the individual spontaneously regains consciousness but may experience confusion or injury sustained during the episode.

A generalized tonic-clonic seizure occurs in four distinct phases:

  • Aura Phase (Pre-seizure Warning):
    • Occurs in approximately 50% of patients and lasts less than 10 seconds.
    • This is a brief warning sensation that can include: Unusual sounds or flashes of light, a peculiar taste in the mouth, feelings of weakness, dizziness, or numbness in a limb, or a brief stomach pain.
  • Tonic Phase (Stiffening):
    • If an aura is present, this phase follows immediately.
    • Characterized by a complete loss of consciousness and falling.
    • All muscles contract, causing the body to become rigid and hyperextended.
    • Often accompanied by a cry as air is forcefully expelled through tightened vocal cords.
    • This phase typically lasts for about 20 seconds.
  • Clonic Phase (Jerking):
    • Follows the tonic phase.
    • Involves repeated, rhythmic contractions and relaxations of all body muscles.
    • Results in gross motor activity, including jerking of the limbs.
    • During this phase, bladder control may be lost, and in rare cases, bowel control.
    • Frothy saliva may come from the mouth; it can be blood-stained if the tongue or lips were bitten.
    • This phase lasts between 30 to 90 seconds.
  • Deep Sleep / Post-convulsive Phase (Post-ictal Period):
    • The individual enters a deep sleep that can last for up to two hours.
    • Upon waking, confusion and disorientation are common for several minutes.
    • Headache is a frequent complaint.
    • Amnesia for the entire seizure event is typical.
  • 2. Absence Seizures (Formerly "Petit Mal Epilepsy")

    Absence seizures are a minor form of epilepsy, commonly occurring in children. They are often mistaken for daydreaming due to their subtle nature and lack of a dramatic convulsion or fall.

    • Brief Loss of Awareness: A sudden, brief interruption of consciousness, typically lasting 15 seconds or less.
    • Staring Spells: The person will typically stop moving and stare blankly in one direction.
    • No Fall: The individual usually does not fall down and is often unaware that a seizure has occurred.
    • Subtle Movements: Slight muscle contractions may occur, but bladder control is rarely lost.
    • Rapid Recovery: Normal alertness returns immediately after the episode, though the person may not recall the event.
    • Childhood Onset: Often begins in childhood and may resolve during adolescence, or in some cases, evolve into other seizure types.
    • Impact on Daily Life: Frequent episodes can lead to poor academic performance or appear as a child dropping objects unknowingly.
    3. Atonic Seizures (Drop Attacks)

    Atonic seizures are characterized by a sudden and complete loss of muscle tone.

    • Sudden Muscle Relaxation: The body goes limp, causing the person to slump or collapse.
    • Risk of Injury: The sudden fall can lead to significant injury.
    • Associated Syndromes: Atonic seizures are a hallmark of certain epilepsy syndromes, such as Lennox-Gastaut syndrome.
    4. Myoclonic Seizures

    Myoclonic seizures involve sudden, brief, shock-like muscle jerks or increases in muscle tone.

    • Sudden "Jolts": The person experiences abrupt, involuntary jerks, similar to those sometimes felt when falling asleep (sleep myoclonus).
    • Repetitive Nature: Myoclonic seizures can occur in bouts, potentially causing harm if they lead to falls or dropped objects.
    Infantile Spasms (A Subtype of Myoclonic Epilepsy)
    • Onset: Typically begins between 3 and 12 months of age and can persist for several years.
    • Presentation: Consist of a sudden jerk followed by stiffening. Often, the child's arms fling outward as the knees pull up and the body bends forward.
    • Duration: Each spasm lasts only a second or two but usually occurs in a series, close together.
    • Misdiagnosis: Sometimes mistaken for colic, but colic cramps do not typically occur in a series.
    • Timing: Most common just after waking up or falling asleep.
    • Severity: This is a particularly severe form of epilepsy that requires prompt evaluation and treatment due to its potential lasting effects on child development.
    5. Focal Seizures (Starting in One Area)

    Focal seizures, previously known as partial seizures, originate in a specific area of the brain. The symptoms depend entirely on the brain region affected.

    a. Jacksonian Epilepsy (Motor Focal Seizures)

    Jacksonian epilepsy refers to a type of focal seizure that begins in the motor sensory area of the cerebral cortex.

    • Localized Onset: Disrupts the function of a particular body part due to excessive electrical discharges from a focal point in the brain.
    • "March" of Symptoms: Symptoms may begin in a small area (e.g., twitching in a thumb or finger) and then gradually spread to involve an entire limb or even the whole side of the body.
    • Secondary Generalization: The seizure can insidiously or gradually spread to become a generalized tonic-clonic seizure.
    b. Temporal Lobe Epilepsy (Focal Seizures with Impaired Awareness)

    Temporal lobe seizures begin in the temporal lobes, which are critical for processing emotions, memory, and language. These lobes are vulnerable to conditions like anoxia at birth, anatomical defects, or scarring.

    • Variable Awareness: The patient may remain partially aware during some temporal lobe seizures. However, in more intense seizures, the individual might appear awake but be unresponsive, displaying repetitive, purposeless movements.
    • Automatisms: Common automatisms (repetitive movements) include: Chewing, Swallowing, Lip smacking, Unusual finger movements (e.g., picking motions).
    • Emotional and Sensory Symptoms: Symptoms can be related to the temporal lobe's functions, leading to:
      • Odd feelings like euphoria, déjà vu (a feeling of having experienced something before), or fear.
      • A sudden, strange odor or taste.
      • A rising sensation in the abdomen.
    • Aura (Warning Sensation):
      • An unusual sensation, or aura, often precedes a temporal lobe seizure, acting as a warning. Not everyone experiences or remembers auras.
      • The aura is the initial part of the focal seizure before consciousness is significantly impaired.
      • Examples include: a sudden sense of unprovoked fear or joy, déjà vu, or a strange smell/taste.
    • Duration: Typically lasts 30 seconds to two minutes for seizures with impaired awareness.
    • Post-seizure (Post-ictal) Period: After a temporal lobe seizure, the patient may experience: A period of confusion and difficulty speaking, Inability to recall what occurred during the seizure, Unawareness of having had a seizure, Extreme sleepiness.
    • Potential for Generalization: In some cases, a temporal lobe seizure can evolve into a generalized tonic-clonic seizure.
    • Treatment: Primarily treated with medication. For individuals unresponsive to medication, surgery may be an option.
    Key Terminology:
    • Tonic: Refers to stiffening of the muscles.
    • Clonic: Refers to jerking of the muscles.
    • Tonic-Clonic: Involves both stiffening followed by jerking.
    • Atonic: Characterized by a loss of muscle tone, causing the body to go limp.
    • Myoclonic: Involves recurrent, brief jerks of a body part.
    ILAE Classification: Seizure and Epilepsy Types

    The International League Against Epilepsy (ILAE) classification provides a detailed framework for understanding seizures (the event) and epilepsy (the underlying condition).

    Table 1: Classification of Seizure Types (The Event)
    Seizure Type Category Subtype Key Characteristics & Observable Features Correlation with Previous Notes
    I. Focal Onset Seizures Focal Aware Seizure
    • Originates in one area/hemisphere of the brain.
    • Consciousness preserved throughout.
    • "Aura" is now understood as a Focal Aware Seizure with specific sensory, emotional, cognitive, or autonomic symptoms (e.g., peculiar taste, dizziness, abdominal rising sensation, déjà vu).
    Directly correlates with "Aura phase" from Grand Mal and early symptoms of Temporal Lobe/Jacksonian seizures.
    Focal Impaired Awareness Seizure
    • Originates in one area/hemisphere of the brain.
    • Consciousness is impaired at any point (dazed, confused, unresponsive).
    • Motor Features: Automatisms (e.g., chewing, lip smacking, picking motions), atonic (localized limpness), clonic (localized jerking), epileptic spasms, hyperkinetic (fidgeting, thrashing), myoclonic (localized jerks), tonic (localized stiffening).
    • Non-Motor Features: Autonomic (e.g., heart rate changes), behavioral arrest, cognitive (e.g., difficulty speaking), emotional (e.g., unprovoked fear or joy), sensory experiences (e.g., strange smell/taste).
    Correlates with Temporal Lobe Epilepsy (purposeless repetitive movements, unresponsiveness) and Jacksonian Epilepsy (localized twitching/tremors).
    Focal to Bilateral Tonic-Clonic Seizure
    • A focal seizure (aware or impaired awareness) that then spreads to involve both hemispheres, leading to a generalized tonic-clonic event.
    • Includes the Tonic phase (sustained stiffening, falling, cry), Clonic phase (rhythmic jerking, potential bladder/bowel release, frothy/blood-stained saliva), followed by a Post-ictal phase.
    Corresponds to what was previously often described as "Grand Mal Epilepsy" particularly if it began with an "aura."
    II. Generalized Onset Seizures Tonic-Clonic
    • Originates rapidly in both hemispheres from the outset.
    • Consciousness typically impaired immediately.
    • Classic sequence: Tonic phase (total body stiffening, loss of consciousness, fall, epileptic cry) followed by Clonic phase (repeated, rhythmic jerking of all muscles, potential incontinence, tongue/lip biting), ending in a Post-ictal phase (deep sleep, confusion, headache, amnesia).
    Corresponds to "Grand Mal Epilepsy" (Generalized Tonic-Clonic Epilepsy) when there's no preceding focal onset/aura.
    Tonic
    • Sustained stiffening of muscles throughout the body, without a subsequent clonic phase.
    • Consciousness typically impaired.
    Relates to the stiffening aspect of "Tonic and Clonic Seizures."
    Clonic
    • Rhythmic jerking movements of muscles throughout the body, without a preceding tonic phase.
    • Consciousness typically impaired.
    Relates to the jerking aspect of "Tonic and Clonic Seizures."
    Atonic
    • Sudden, generalized loss of muscle tone; body goes limp, slump or collapse ("drop attacks").
    • Consciousness typically impaired.
    Directly correlates with Atonic Seizures (Drop Attacks).
    Myoclonic
    • Brief, shock-like jerks or increases in muscle tone, affecting muscles or muscle groups.
    • Can occur in bouts.
    Directly correlates with Myoclonic Seizures.
    Epileptic Spasms
    • Sudden flexion or extension of the body (e.g., arms fling outward, knees pull up, body bends forward).
    • Often occur in clusters.
    Directly correlates with Infantile Spasms.
    Typical Absence
    • Brief (seconds) staring spells with unresponsiveness.
    • Often mistaken for daydreaming.
    • May involve subtle automatisms.
    • Consciousness impaired.
    Directly correlates with "Petit Mal Epilepsy" (Absence Seizures).
    Other Absence Types Atypical Absence, Myoclonic Absence, Eyelid Myoclonia (more specific subtypes).
    III. Unknown Onset Seizures -
    • When the beginning of the seizure is not observed or cannot be determined.
    • May later be reclassified once more information is available.
    Applies when the initial moments of an event (e.g., a Tonic-clonic seizure or Epileptic spasm) are unwitnessed.
    Table 2: Pre-Seizure and Post-Seizure Stages
    Stage Characteristics
    Prodrome
    • Non-specific symptoms occurring hours or days before a seizure.
    • Not part of the seizure activity itself.
    • Examples: Mood changes (irritability, depression), talkativeness, restlessness, violence.
    Post-ictal Stage
    • The period immediately after a seizure as the brain recovers.
    • Symptoms vary based on seizure type and intensity.
    • Examples: Confusion, fatigue, headache, amnesia for the event, disorientation, emotional changes (calmness, quietness, isolation, retarded mobility, depression).
    Clinical Manifestations (What Epilepsy Looks Like)

    Clinical manifestations are the signs and symptoms that occur during a seizure event and can be highly varied, depending on the seizure type and the brain region involved.

    1. Generalized Onset Seizures:
  • Generalized Tonic-Clonic Seizure (formerly Grand Mal):
    • Prodrome (Pre-ictal): Hours or days before the seizure, the person may experience non-specific symptoms like mood changes, irritability, or difficulty concentrating.
    • Aura (often absent or not remembered if truly generalized onset): If present, it would indicate a focal onset that rapidly generalized.
    • Tonic Phase: Sudden loss of consciousness, body stiffens symmetrically, often a cry or groan (as air is forced out). Person falls to the ground. Eyes roll back. Breathing may stop briefly, leading to cyanosis. Lasts usually 10-30 seconds.
    • Clonic Phase: Rhythmic jerking of the limbs and body, typically bilateral. May involve tongue biting (often side of tongue), incontinence (bladder and rarely bowel), frothing at the mouth (which can be blood-stained from biting). Lasts usually 30 seconds to 2 minutes.
    • Post-ictal Phase: Gradual recovery of consciousness. Confusion, drowsiness, headache, muscle aches, and complete amnesia for the event are typical. May enter a deep sleep. Can last minutes to hours.
  • Absence Seizures (formerly Petit Mal):
    • Onset: Typically abrupt, without warning.
    • Manifestations: Brief (seconds, typically <15-20 sec) episodes of staring, blank expression, unresponsiveness. May involve subtle automatisms like eyelid fluttering, lip-smacking, or mild head nodding.
    • Termination: Abrupt. The individual quickly resumes prior activity, often unaware of the seizure or with immediate return of alertness. No post-ictal confusion.
    • Typical Population: Most common in children, often mistaken for daydreaming or inattention.
  • Myoclonic Seizures: Sudden, brief, shock-like jerks or twitches of a muscle or group of muscles (e.g., arms, shoulders, head). Often bilateral but can be unilateral. Consciousness usually preserved.
  • Atonic Seizures (Drop Attacks): Sudden, brief loss of muscle tone, causing the person to fall abruptly to the ground, often without warning. High risk of head and facial injury.
  • Tonic Seizures: Sudden, brief stiffening or tensing of muscles, typically in the trunk and limbs. Can cause falls.
  • Clonic Seizures: Rhythmic jerking movements, usually symmetrical, but without the preceding tonic phase.
  • 2. Focal Onset Seizures:
  • Focal Aware Seizures (formerly Simple Partial):
    • Manifestations: Vary widely depending on the brain region affected, but consciousness is fully preserved. The person is aware of the event.
    • Motor: Twitching, jerking, or stiffening of a specific body part (e.g., face, arm, leg). "Jacksonian March" describes the spread of motor symptoms.
    • Sensory: Tingling, numbness, visual disturbances, auditory hallucinations, olfactory, gustatory, or vertigo.
    • Autonomic: Changes in heart rate, breathing, sweating, epigastric rising sensation, flushing, pallor.
    • Psychic/Cognitive/Emotional: Feelings of fear, anxiety, déjà vu, jamais vu, memory disturbances. Often experienced as an "aura" before evolving to a more complex seizure.
  • Focal Impaired Awareness Seizures (formerly Complex Partial):
    • Manifestations: Consciousness is impaired or lost. The person may appear to be awake but is unresponsive, confused, or has an altered state of awareness.
    • Automatisms: Repetitive, non-purposeful movements are common (e.g., lip-smacking, chewing, swallowing, fumbling with clothes, walking aimlessly, repeating phrases). These are characteristic of temporal lobe seizures.
    • Duration: Typically 30 seconds to 2 minutes.
    • Post-ictal Phase: Common, characterized by confusion, drowsiness, and often amnesia for the seizure event.
  • Focal to Bilateral Tonic-Clonic Seizure: Begins with symptoms of a focal seizure (e.g., an aura, focal motor activity, or impaired awareness), then rapidly progresses to a generalized tonic-clonic seizure with loss of consciousness.
  • Diagnosis of Epilepsy

    Diagnosing epilepsy involves confirming that the events are indeed epileptic seizures, classifying the seizure type, identifying the epilepsy syndrome, and determining the etiology.

    1. Clinical History (The Most Crucial Step):
    • Detailed Seizure Description: A meticulous history from the patient (if possible) and, crucially, from an eyewitness (family member, friend, colleague) is paramount. Questions focus on:
      • Pre-event: Prodrome, triggers, warning signs (aura).
      • During the Event: Onset (sudden vs. gradual), movements (type, location, symmetry), vocalizations, eye movements, head turning, color changes, incontinence, tongue biting, level of awareness/responsiveness.
      • Post-event: Duration of confusion, memory of the event, fatigue, headache, muscle soreness.
    • Medical History: Birth history, developmental milestones, head injuries, CNS infections, fevers, family history of epilepsy, past medical conditions, medications, drug/alcohol use.
    2. Neurological Examination:
    • Usually normal between seizures, but may reveal focal deficits if there is an underlying brain lesion (e.g., hemiparesis, sensory loss). Post-ictally, transient neurological deficits (Todd's paralysis) can be observed.
    3. Electroencephalography (EEG):
    • Purpose: Records the electrical activity of the brain to identify abnormal brain wave patterns (epileptiform discharges).
    • Interictal EEG: Performed between seizures. Can show characteristic patterns (e.g., spikes, sharp waves) that support a diagnosis. A normal interictal EEG does not rule out epilepsy.
    • Ictal EEG: Performed during a seizure (e.g., during video-EEG monitoring). Captures the actual seizure activity and is the most definitive EEG finding for diagnosis and localization.
    • Activation Procedures: Hyperventilation, photic stimulation, and sleep deprivation are used to provoke epileptiform activity.
    4. Neuroimaging:
    • Magnetic Resonance Imaging (MRI) of the Brain:
      • Purpose: To identify structural abnormalities causing seizures (e.g., tumors, strokes, malformations, mesial temporal sclerosis).
      • Importance: Crucial for identifying the etiology, especially in focal epilepsies.
    • Computed Tomography (CT) Scan of the Brain: Less sensitive than MRI but can be used in emergency situations (e.g., to rule out acute hemorrhage).
    5. Blood Tests and Other Laboratory Investigations:
    • To rule out other conditions that can cause seizures (e.g., metabolic derangements, infections, drug/alcohol withdrawal, electrolyte imbalances). Examples: CBC, electrolytes, glucose, liver/kidney function tests, toxicology screen.
    6. Video-EEG Monitoring:
    • Continuous simultaneous recording of EEG and video of the patient over several days. Gold standard for confirming diagnosis, classifying seizure types, and localizing onset zone for surgery.
    Management and Treatment Options for Epilepsy

    The management of epilepsy is multifaceted, encompassing immediate care during a seizure, long-term pharmacological and non-pharmacological treatments, addressing complications, and providing comprehensive patient education.

    I. Immediate Management and First Aid During a Seizure (Emergency Management):

    A seizure can be frightening for bystanders, but knowing how to act can prevent injury and ensure patient safety.

    1. General Principles of Emergency Management:
    • Stay Calm: Remain composed and speak calmly.
    • Safety First: Remove the person from immediate danger (e.g., clear sharp objects). If the patient is safe, do not move them.
    • Time the Seizure: Note the exact start time. Crucial for determining if medical help is needed.
    • Loosen Clothing: Around the neck to ease breathing.
    • Protect the Head: Support with a soft, flat material (e.g., folded jacket).
    • Ensure Airflow: Clear space and minimize crowds.
    • Recovery Position: As soon as jerking stops, turn onto side to prevent choking.
    • Check Breathing: If breathing sounds difficult after the seizure, call for an ambulance.
    • Clear Airway: Gently check for blocks (e.g., false teeth) but do not force mouth open.
    • Stay with Patient: Until fully awake and reoriented.
    • Reassurance: Reorient and reassure the patient after recovery.
    2. What NOT to Do During a Seizure:
    • Do not put any hard object (e.g., spoon) in the person's mouth.
    • Do not hold their limbs tightly.
    • Do not give anything to eat or drink until fully alert.
    • Do not attempt mouth-to-mouth resuscitation (unless breathing doesn't resume after seizure).
    3. When to Call for Emergency Medical Help:
    • The person has never had a seizure before.
    • The person has difficulty breathing or waking up after the seizure.
    • The seizure lasts longer than 5 minutes (Potential Status Epilepticus).
    • The person has another seizure soon after the first one without full recovery.
    • The person is hurt during the seizure.
    • The seizure happens in water.
    • The person has a pre-existing health condition like diabetes, heart disease, or is pregnant.
    II. Long-Term Medical Management (Drug Management):

    The cornerstone of long-term epilepsy treatment is typically anti-seizure medications (ASMs).

    1. Principles of Pharmacological Treatment:
    • Goal: Reduce frequency of seizures or eradicate them.
    • Individualized Treatment: Based on seizure type, age, comorbidities.
    • Titration: Start low and gradually increase.
    • Monitoring: Regular follow-ups for progress and side effects.
    • Monotherapy vs. Polytherapy: Start with one drug; add others if needed.
    2. Commonly Used Anti-Seizure Medications:
    • Phenobarbitone: Typically 30 to 90 mg two to three times daily (divided doses). An older, broad-spectrum ASM.
    • Phenytoin Sodium: Typically 100-300 mg daily (DDD - once daily or divided doses). Effective for focal and generalized tonic-clonic seizures.
    • Sodium Valproate (Valproic Acid): Typically 200-1200 mg two to three times daily (divided doses). Broad-spectrum, effective for various seizure types.
    • Carbamazepine: Typically 100-1200 mg in 3 divided doses. Primarily used for focal seizures.
    3. General Principles of the Treatment of Epilepsy:
    • Treat Causative Factors: Treat underlying causes like malaria, meningitis, or cerebral growths.
    • Avoidance of Precipitating Factors: Identify and avoid triggers.
    • Anticipation of Natural Variation: Understand seizure timing (e.g., during sleep).
    • Appropriate and Regular Administration: Strict adherence to prescribed regimen.
    Seizure Triggers & Complications
    Seizure Triggers:
    • Physiological Stressors: Fevers, sleep deprivation, fasting.
    • Emotional Stressors: Fear, anger, excitement.
    • Sensory Stimuli: Flickering lights (photosensitivity), specific sounds.
    • Substance Use: Alcohol intoxication or withdrawal.
    • Environmental Factors: Fatigue, boredom, high altitude.
    • Hormonal Changes: Menstrual cycle fluctuations.
    • Medication Non-adherence.
    Complications of Epilepsy:
    1. Status Epilepticus: A medical emergency defined by a seizure lasting longer than 5 minutes, or recurrent seizures without return to baseline consciousness. Requires urgent medical treatment.
    2. Mental Deterioration (Cognitive Impairment): Chronic brain syndrome where repeated seizures can lead to progressive brain damage.
    3. Physical Injuries: Falls, burns, fractures.
    4. Psychosocial Issues: Stigma, anxiety, depression, social isolation.
    5. SUDEP (Sudden Unexpected Death in Epilepsy): The most common cause of epilepsy-related death where no other cause is found.
    Patient and Community Education & Prevention
    For Patients and Caretakers:
    • Epilepsy is an illness like any other; with treatment, a person can lead a full life.
    • Encourage participation in activities safely.
    • Emphasize importance of taking medications exactly as prescribed.
    • Advise against dangerous activities (swimming alone, driving until seizure-free, operating heavy machinery).
    For the Community:
    • Combat Stigma: Educate that labeling patients is traumatizing.
    • Inclusion: Children should attend school; adults should be encouraged to marry.
    • Contagion: Teach that epilepsy is not contagious.
    Prevention of Epilepsy:
    • Prevent Head Injury (seat belts, helmets).
    • Seek Immediate Medical Attention after a first seizure.
    • Good Prenatal Care.
    • Manage Cardiovascular Risk Factors (hypertension).
    • Avoid Excess Alcohol Abuse.
    • Manage Fevers in Children.
    • Treat Infections and Ensure Nutrition.
    Nursing Diagnoses and Specific Nursing Interventions
    Nursing Diagnosis 1: Risk for Injury

    Related to uncontrolled seizure activity, loss of consciousness, uncontrolled muscle movements, or falls during seizures.

    Specific Nursing Interventions Details
    Seizure Precautions Pad side rails, keep bed in lowest position, instruct to avoid sharp objects in environment, recommend medical alert bracelet.
    Seizure First Aid Stay with patient, protect head, loosen clothing, turn to recovery position, move furniture, DO NOT restrain or insert objects in mouth, time the seizure.
    Post-Ictal Monitoring Monitor vital signs, level of consciousness, assess for injuries, allow rest, reorient gently.
    Activity Modification Educate on avoiding swimming alone, driving restrictions, and home modifications (e.g., shower chair).
    Nursing Diagnosis 2: Ineffective Airway Clearance

    Related to neuromuscular impairment during tonic-clonic seizures (tongue biting, increased salivary secretions, aspiration risk).

    Specific Nursing Interventions Details
    Acute Seizure Management Do not attempt to open mouth during seizure. Once movements cease, turn to recovery position to facilitate drainage. Suction secretions as needed.
    Post-Ictal Assessment Monitor respiratory rate/depth, assess breath sounds for aspiration (crackles), monitor for hypoxia.
    Patient Education Educate family on recovery position importance and when to call for emergency help if breathing is compromised.
    Nursing Diagnosis 3: Inadequate Health Knowledge

    Regarding epilepsy (disease process, triggers, medication regimen, first aid, emergency protocols).

    Specific Nursing Interventions Details
    Comprehensive Education Explain disease process, ASM purpose/dose/side effects, importance of daily dosing, triggers, first aid, and emergency protocols (e.g., seizure >5 min).
    Resources Provide written materials and support group info.
    Teach-Back & Reinforcement Ask patient to explain back what they learned; reinforce at every visit.
    Nursing Diagnosis 4: Excessive Anxiety

    Related to unpredictable nature of seizures, fear of public seizures, social stigma.

    Specific Nursing Interventions Details
    Establish Trust Provide non-judgmental environment to express fears.
    Empowerment Address knowledge deficits to reduce anxiety; emphasize productive lives are possible.
    Coping Strategies Encourage relaxation techniques, mindfulness, support group participation.
    Referrals & Stigma Refer to mental health professionals if needed; discuss strategies for talking to employers/friends.
    Nursing Diagnosis 5: Impaired Social Interaction

    Related to fear of seizures in public, stigma, withdrawal, or limitations on activities.

    Specific Nursing Interventions Details
    Address Anxiety/Deficits Educate to dispel myths; help patient develop confidence in disclosing condition.
    Promote Participation Discuss safe activities (e.g., cycling with supervision), public transport options, encourage social groups.
    Support & Advocacy Recommend support groups; advocate for patient in social settings by educating others on first aid.
    Nursing Diagnosis 6: Noncompliance (Medication Adherence)

    Related to perceived side effects, forgetfulness, or lack of understanding.

    Specific Nursing Interventions Details
    Detailed Teaching Explain "why" consistent use prevents complications. Review side effects and strategies to manage them.
    Adherence Strategies Suggest pill organizers, alarms, linking to daily routines. Discuss refilling prescriptions early.
    Address Beliefs Explore beliefs/misconceptions. Involve family in medication management if appropriate.
    Nursing Diagnosis 7: Fatigue

    Related to post-ictal state, sleep disturbance, or side effects of anti-seizure medications.

    Specific Nursing Interventions Details
    Assessment & Sleep Hygiene Assess fatigue severity. Educate on regular sleep schedules, avoiding caffeine/alcohol before bed.
    Medication Review Collaborate with physician if ASMs cause excessive sedation.
    Energy Conservation Teach pacing activities and prioritizing tasks.
    Healthy Lifestyle Encourage regular exercise and balanced diet. Allow adequate rest post-seizure.

    Epilepsy Read More »

    Anxiety Disorders

    Anxiety Disorders

    ANXIETY DISORDERS

    All children have worries and fears from time to time. Whether it’s the monster in the closet, the big test at the end of the week, or any other thing, kids have things that make them anxious, just like adults.

    But sometimes anxiety in children crosses the line from normal everyday worries to a disorder that gets in the way of the things they need to do. It can even keep them away from enjoying life as they should.

    How can to tell if the child’s anxieties might be more than just passing worries and fears? Here are some questions to ask oneself:

    • Are they expressing worry or showing anxiety on most days, for weeks at a time?
    • Do they have trouble sleeping at night? If you aren’t sure (they might not tell you), do you notice that they seem unusually sleepy or tired during the day?
    • Are they having trouble concentrating?
    • Do they seem unusually irritable or easy to upset?

    There are several different types of anxiety disorders that can affect children. The most common include:

    Generalized Anxiety Disorder (GAD)

    Children and adolescents with generalized anxiety disorder have persistent, excessive, and unrealistic worries that are not focused on a specific object or situation. A child may worry excessively about his or her;

    • performance at school or in activities such as sports
    • about personal safety and that of family members,
    • or about natural disasters.

    Children with generalized anxiety have a hard time “turning off” their worrying, which leads to difficulty concentrating, learning, and participating in social situations. Some children may be insecure and frequently seek reassurance, while others may be self-conscious, self-doubting, or overly concerned about meeting other people’s expectations. Generalized anxiety disorder typically affects school-aged children and adolescents.

    Kids with GAD may experience physical symptoms because they are so overwhelmed by their worries;

    • headaches 
    • isolating themselves
    • avoiding school
    • Avoiding friends.

    Panic Disorder

    A panic attack is a sudden, intense episode of anxiety with no apparent outside cause.

    Some children or adolescents may experience extreme discomfort or fear when in certain situations or places, resulting in a panic attack.

    Symptoms may include;

    • shortness of breath
    • pounding heart
    • Tingling sensations throughout the body.
    • Child may tremble or feel dizzy or numb. (If your child is hyperventilating, try to have them breathe slowly with nice deep breaths.)

    Although severe anxiety may result in a panic attack, a child with panic disorder often has symptoms of panic without any apparent trigger. Unlike the occasional, mild worries children often experience.

     A panic attack may dramatically affect a child’s life by interrupting his or her normal activities. Often, a child becomes preoccupied with worry about possible future attacks. Panic disorder tends to begin during adolescence, although it may start during childhood, and sometimes runs in families.

    Separation Anxiety Disorder

    Most children have some level of separation anxiety as its a normal phase of development in babies and toddlers. Even older children may get clingy with their parents or caregivers occasionally, especially in new settings.

    But older children who get unusually upset when leaving a parent or someone else close to them, who have trouble calming down after saying goodbye, or who get extremely homesick and upset when away from home at school, camp, or play dates, may have separation anxiety disorder.

    Children with separation anxiety disorder experience significant fear and distress about being away from home or their caregivers. This fear affects a child’s ability to function socially and academically. For example, a child may have a hard time making friends or maintaining relationships because he or she refuses to go on play dates without a parent, or sleep without being near a parent or caregiver.

    Social Phobia

    Social phobia, also known as social anxiety disorder, is an excessive fear of being rejected, humiliated, or embarrassed in front of others. A child with social phobia feels severe anxiety and self-consciousness in normal, everyday, social situations. This is more than just shyness.

    The socially anxious child is terrified that they will embarrass themselves when talking with classmates, answering a question in class, or doing other normal activities that involve interacting with others.

    This fear can keep the child from participating in school and activities. Some children may even find themselves unable to talk at all in some situations.

    Children and adolescents with social phobia worry about a wide range of situations, such as;

    • speaking in front of a group
    • participating in class
    • talking to adults or peers
    • starting or joining in conversations
    • eating in public.
    • They may fear unfamiliar people
    • have difficulty making friends
    • can also be limited to specific situations e.g. adolescents may fear dating and recreational events, for instance
    • but they may be confident in academic and work settings.

    Children and teenagers with social phobia typically avoid the situations they fear—by staying home from school or shunning parties, for instance. Although the condition can occur in children as young as age four, it is more common among adolescents. The average age of onset is 13.

    Obsessive-Compulsive Disorder 

    Children with obsessive-compulsive disorder (OCD) have obsessions ie; these are intrusive, unwanted thoughts. To relieve the anxiety associated with those thoughts, they perform compulsions, or repetitive actions, rituals, or routines.

     Compulsions may involve washing, counting, organizing objects, or reading a passage of text over and over.

    For children with OCD, these thoughts and behaviors significantly interfere with their daily functioning and can cause distress and embarrassment. OCD can develop at any age, but it’s most likely to occur between the ages of 8 and 12, in late adolescence, or early adulthood.

    Specific Phobias     

    Fears are common in childhood and are usually outgrown as a child matures. For some children and teens, however, fears can become severe. If a fear is excessive and persistent it may be a phobia, or an intense irrational fear of a specific object or situation.

    Phobias differ from usual fears in that they don’t decrease with reassurance, and they interfere with a child’s life. Children may develop phobias as early as age five. Specific phobias commonly involve animals, insects, heights, thunder, driving, dental or medical procedures, elevators etc.

    Selective Mutism

    Children with selective mutism speak freely in familiar situations but become mute in specific situations or around certain people. Some children with selective mutism may avoid eye contact and refuse to communicate with others. Others may enjoy the company of others but remain silent or have a close friend speak for them. Selective mutism typically affects preschool-aged children and those in elementary school, usually before age 10.

    Management

    Mental health professionals today understand much more about childhood anxiety disorders than in the past. No matter what the child’s anxiety disorder is, a professional health worker  can help.

    but the care giver has to be advised about the following for the child at home by being supportive and understanding.

    • If the child becomes upset and anxious, stay calm and talk to them through it.
    • Don’t punish the child for things like mistakes on schoolwork or lack of progress.
    • “Catch” them doing well: Praise even small accomplishments, and be specific.
    • Plan for transitions. If the child’s anxiety means going to school in the morning is very stressful, allow plenty of extra time.
    • While respecting  the child’s privacy, do give their teachers and coaches information they need to help them understand what’s going on.

    Above all, be available to listen when the child wants to talk to you about their anxiety. Kids with anxiety disorders often try to hide their fears because they think you won’t understand. So let the child know you’re ready to listen whenever they’re ready to talk

    Anxiety Disorders Read More »

    Mental Retardation

    Mental Retardation

    Mental Retardation

    Mental retardation is a generalized neurodevelopment disorder characterised by significantly impaired intellectual and adaptive disorder present before age of 18yrs.

    Mental retardation refers to significantly sub-average general intellectual functioning resulting in or associated with concurrent impairments in adaptive behaviour as manifested during the developmental period

    This is characterised by below mental ability and average intelligence or lack of skills necessary for day to day living. People with mental retardation can and do learn new skills, but they learn them more slowly.

    People with intellectual disability have the following limitations

    • Intellectual functioning also known as (intelligence quotient) IQ

    This refers to a person’s ability to learn reason, make decisions, and solve problems.  Intelligence quotient is measured test of which the average is 100 and a person is considered intellectually disabled if the IQ is less than 70%

    • Adaptive behaviours

    These are degrees with which the individual meets the standards of personal dependence and social responsibility expected of his age and cultural group.

    These are skills necessary for day to day life such as being able to communicate effectively, interact with others and take care of one’s self.

    Classification of Mental Retardation

    Intelligence quotient is the ratio between mental age (MA) and chronological age (CA) where chronological age is determined from the date of birth and mental age is determined by the intelligence tests.

    • Mild mental retardation
    • Moderate mental retardation
    • Severe mental retardation
    • Profound
    Mild mental retardation (educable)

    These have IQ levels ranging from 50 to 69%. These children go undiagnosed until they reach school years. They are often slower to talk, walk and feed themselves as compared to other children. They can learn domestic and practical skills including reading and maths and achieve good independence in self-care like eating, washing, dressing etc. They can build social and job skills and can live on their own.

     

    Moderate mental retardation (trainable)

    These have IQ ranging from 35 to 49%.

    Children with mild mental retardation show noticeable delays in developing speech and motor skills. Although they are unlikely to acquire useful academic skills, they can learn basic communication, some health and safety habits and other simple skills. They cannot learn how to read or do maths. Moderately retarded adults cannot live alone and need supervision throughout life but can do simple tasks and travel alone to familiar places.

    Severe mental retardation (dependent retarded)

    These have IQ ranging from 20 to 34%

    This condition can be diagnosed as early as at birth or very soon after birth. By preschool age, they show delays in motor development and little or no ability to communicate. With good training, they can learn self-help skills such as how to feed or bath themselves. They usually learn to walk and gain basic understanding of speech as they get older.

    Adults with severe mental retardation may be able to follow daily routines but need through supervision and to be kept in a protected environment.

    Profound mental retardation (life support)

    Only a few people with mental retardation have IQ below 20%.

    This condition is diagnosed at birth and is associated with other medical problems which require nursing care. The children show delays in all aspects of development.

    Most individuals are immobile, have limited ability to understand, are unable to care for themselves, have various neurological and physical disabilities, visual and hearing abilities are impaired and so many other associated disabilities.

    Causes of Mental Retardation

    Mental retardation is a complex action which may be caused by interaction of many factors and in 75% of patients, the cause is unknown.

    Genetic factors

    • If one or both parents have mental retardation, chances that children develop this condition are high.
    • Sometimes mental retardation is caused by abnormalities of chromosomes rather than individual genes e.g. down syndrome where an individual has an extra chromosome in the cell.

    Problems during pregnancy

    • Infections in pregnancy like TORCHES; toxoplasmosis, Rubella, Cytomegalovirus, Syphilis, herpes simplex.
    • Alcohol in pregnancy may cause mental retardation through Fetal Alcohol Syndrome FAS
    • Placental dysfunction like toxaemia of pregnancy, placenta previa, cord prolapse etc.
    • Some drugs like cocaine when taken in pregnancy may harm mental development of unborn child.
    • Maternal malnutrition
    • Exposure to radiations

    Problems during birth (perinatal factors)

    • Prematurity
    • Very low birth weight
    • Instrumental delivery
    • Prolonged labour
    • Kernicterus
    • Birth asphyxia

    Problems after birth (postnatal factors)

    • Lead or mercury poisoning
    • Severe malnutrition
    • Accidents that cause severe head injury
    • Diseases such as meningitis, encephalitis etc.
    • Untreated hypothyroidism
    • Brain tumours
    • Epilepsy

    Environmental causes

    • Cultural deprivation
    • Low socio-economic status
    • Inadequate caretakers
    • Child abuse

    Signs and symptoms of mental retardation

    These vary greatly depending on the severity of the condition

    • IQ below 70%
    • Failure to achieve developmental milestones
    • Delay in oral language development
    • Deficit in memory skills
    • Difficult learning social roles
    • Difficult with problem solving skills
    • Decreased learning abilities or inabilities to meet education demands at school
    • Limited motor and communication skills
    • Visual and hearing impairments
    • Epilepsy always accompanies the problem
    • Require constant supervision
    • Neurological disorders are very common
    • Some may have psychotic or behavioural disorders
    • Self-care is a problem to these patients.

    Diagnosis

    This can be made by

    1. IQ testing (MA/CA)X100
    2. Taking history from the parents or care giver
    3. Carrying out biochemical tests
    4. Physical examination
    5. Neurological examination
    6. Assessing developmental milestones
    7. Investigation
    • Urine and blood for metabolic disorders
    • Culture for biochemical studies
    • Amniocentesis in infant chromosomal disorders
    • Chorionic villi sampling
    • Hearing and speech evaluation
    • CT scan or MRI
    • Thyroid function tests when cretinism is suspected
    1. X-ray

    Management of Mental Retardation

    Majority of the mentally retarded children and adults are cared for at home and admission is only required because of incompetent parents, psychotic behaviours, stigmatisation etc.

    Aims

    1. To enable the patient reach his or her maximum potential ability
    2. To ensure safety of the patient.
    • Mentally retarded children are admitted in hospitals or any other institution with schools that offer them training and education suitable to their abilities.
    • Physical training, recreation, and social activities also play a part in treatment regimen
    • Love, attention and care are one of the most required elements for these children
    • Written, verbal and pictorial forms of communication as well as gestures and demonstration are very helpful to ensure mutual understanding and improve treatment adherence
    • Programmes that maximise speech, language, cognition, psychomotor, social, self care and occupational skills have to be encouraged
    • The main stay of treatment is by developing a comprehensive management plan for the condition which includes multiple disciplines like special educators, language therapists, behavioural therapists, occupational therapists and community service providers that provide social support to affected families.
    • On-going evaluation for overlapping psychiatric disorders such as depression, bipolar disorder and ADHD
    • Neuroleptics such as haloperidol are given in cases of psychotic behaviour
    • Analgesics are required for management of pain especially in severe mental retardation.
    • Family therapy to help parents develop coping skills and deal with guilt and anger
    • Early intervention programs for children younger than age 3 with mental retardation
    • Provide day schooling to train the child in basic skills such as bathing and feeding
    • Vocational training
    Prevention of mental retardation

    Preconception

    • Genetic counselling
    • Immunisation of maternal rubella
    • Adequate maternal nutrition
    • Family planning

    During gestation

    • Adequate nutrition
    • Fetal monitoring
    • Protection from diseases
    • Avoidance of teratogenic substances like alcohol and exposure to radiations

    At delivery

    • Delivery should be conducted in the hospital
    • Apgar scoring has to be done at 1 and 5 minutes after the birth of a child
    • Close monitoring of mother and child

    Childhood

    • Improved general medical care for children
    • Improved nutrition for children
    • Proper and early treatment for childhood infections
    • Immunisation of children according to immunisation schedule

    Mental Retardation Read More »

    Substance Abuse

    Substance Abuse

    Substance Abuse

    Substance abuse, as a disorder, refers to the abuse of illegal substances or the abusive use of legal substances. Alcohol is the most common legal drug of abuse.

    SUBSTANCE ABUSE/CHEMICAL DEPENDENCE IN ADOLESCENTS

    Alcohol and other drug use pose a serious threat to health of children and adolescents. In addition to health risks, substance abuse is often linked with other risk behaviors like violence, early sexual activity, truancy and academic failure.

     Pediatricians and other PHC providers are in ideal positions to identify substance abuse and to provide preventive guidance and education to children, adolescents and their families.

    Epidemiology

    Between 1990’s and recent, the prevalence rates of alcohol and other drug abuse among adolescents are increasing. Research has found out that one of every two adolescents has tried an illicit drug by the time he completes high school. The most commonly abused drug is alcohol.

    Definitions

    There are different terms used to define substance-related disorders, including the following:

    Substance abuse; Substance abuse refers to an illegal use of a substance leading to significant problems or distress

    Such as problems might include;

    • failure to attend school
    • substance use in dangerous situations (driving a car)
    • substance-related legal problems
    • interfering with friendships and/or family relationships
    Tolerance; refers to a need for increased amounts of a substance to attain the desired effect.

    Substance dependence

    Substance dependence refers to a compulsive use and continuous relying on a specific substance for both physical and psychological relief with an inability to stop its usage even after significant problems in everyday functioning have developed.

    Signs include;

    • an increased tolerance
    • Withdrawal symptoms with decreased use
    • unsuccessful efforts to decrease use
    • increased time spent in activities to obtain substances
    • withdrawal from social and recreational activities
    • continued use of a substance even with awareness of physical or psychological problems encountered by the extent of the substance use

    Alcohol intoxication; this is a temporary mental disturbance following heavy drinking so that the level of alcohol in blood is high and sufficient to affect someone’s activity, mood and level of consciousness.

    Alcoholism; is a chronic condition where a person takes alcohol excessively and for long period of time thus leading to adverse physical, mental, social and psychological effects

    Alcoholic; is a person who have been taking alcohol excessively and for a long period of time in whom it has cause serious mental, social, psychological and physical problems

    Substances commonly abused by adolescents

    Substances frequently abused by adolescents include, but are not limited to, the following:

    • Alcohol
    • Marijuana
    • Tobacco
    • Prescription drugs 
    • Hallucinogens
    • Cocaine
    • Amphetamines
    • Opiates
    • Anabolic steroids
    • Inhalants
    • Methamphetamine

    Causes of substance abuse

    1.   Cultural and societal norms and acceptable standards of substance use. Public laws determine the legality of the use of substances.

    2.  Genetic vulnerability; it tends to run in families

    3.  Psychological problems such as;

    • -anxiety
    • -stress and frustrations
    • -feelings of desire

    4.  Environmental stressors such as;

    • -failure of exams
    • -worry of the future
    • -failure to achieve a certain goal
    • -child abuse
    • -faulty upbringing
    • -lack of education
    • -large uncontrolled families
    • -economic constraints
    • -rape, incest and defilement

    5.  Social pressures from peers

    6.  Individual personality disorders

    7.  Psychiatric problems such as;

    • -depressive disorder
    • -suicidal intentions
    • -paronea

    Adolescents at risk of substance abuse

    Parental and peer substance use are two of the more common factors contributing to youthful decisions regarding substance use.

    Some adolescents are more at risk of developing substance-related disorders, including adolescents with one or more of the following conditions present:

    • Children of substance abusers
    • Adolescents who are victims of physical, sexual, or psychological abuse
    • Adolescents with mental health problems, especially depressed and suicidal teens
    • Physically disabled adolescents
    • Children whose parents deal with substances for financial support

    Symptoms of substance abuse

    The following behaviors may indicate an adolescent is having a problem with substance abuse. However, each adolescent may experience symptoms differently. Symptoms may include:

    • Getting high on drugs or getting intoxicated (drunk) on a regular basis
    • Lying, especially about if and how much they are using or drinking
    • Avoiding friends and family members
    • Giving up activities they used to enjoy such as sports or spending time with nonusing friends
    • Talking a lot about using drugs or alcohol
    • Believing they need to use or drink in order to have fun
    • Pressuring others to use or drink
    • Getting in trouble at school or with the law
    • Taking risks, such as sexual risks or driving under the influence of a substance
    • Suspension from school for a substance-related incident
    • Missing school due to substance use and/or declining grades 
    • Depressed, hopeless, or suicidal feelings

    Diagnosis of substance abuse

    A pediatrician, family doctor, psychiatrist, or qualified mental health professional usually diagnoses substance abuse in adolescents. However, adolescent substance abuse is believed by some to be the most commonly missed pediatric diagnosis. Adolescents who use drugs are most likely to visit a doctor’s office with no obvious physical findings. Substance abuse problems are more likely to be discovered by doctors when adolescents are injured in accidents occurring while under the influence, or when they are brought for medical services because of intentional efforts to hurt themselves.

    • History taking; this can reveal personal history on substance abuse
    • Clinical presentation; this often depend on the substance abused, the frequency of use, and the length of time since last used, and may include:
    • Weight loss
    • Constant fatigue
    • curly hair
    • Red eyes
    • Little concern for hygiene
    • use of the questionnaire of CAGE

    Treatment for substance abuse

    Specific treatment for substance abuse will be determined based on:

    •  Adolescent’s age, overall health, and medical history
    • Extent of  adolescent’s symptoms
    • Extent of  adolescent’s dependence
    • The substance abused
    •  Adolescent’s tolerance for specific medications or therapies
    • Expectations for the course of the condition
    •  Opinion or preference of the care taker

    A variety of treatment programs for substance abuse are available on an inpatient or outpatient basis. Programs considered are usually based on the type of substance abused.

    Medical detoxification (if needed, based on the substance abused) and long-term follow-up management are important features of successful treatment.

    Long-term, follow-up management usually includes formalized group meetings and age-appropriate psychosocial support systems, as well as continued medical supervision. Individual and family psychotherapy are often recommended to address the developmental, psychosocial, and family issues that may have contributed to and resulted from the development of a substance abuse disorder.

    Prevention of substance abuse

    There are three major approaches used to prevent adolescent substance use and abuse, including the following:

    • School-based prevention programs. School-based prevention programs usually provide drug and alcohol education and interpersonal and behavior skills training.
    • Community-based prevention programs. Community-based prevention programs usually involve the media and are aimed for parents and community groups. Programs, such as Mothers Against Drunk Driving (MADD) and Students Against Drunk Driving (SADD), are the most well-known, community-based programs.
    • Family-focused prevention programs. Family-focused prevention programs involve parent training, family skills training, adolescent social skills training, and family self-help groups. Research literature available suggests that components of family-focused prevention programs have decreased the use of alcohol and drugs in adolescents and improved effectiveness of parenting skills.

    ALCOHOL AND DRUG ADDICTION

    Alcohol and drug addiction have been a source of serious problems for thousands of years. Recent studies indicate that there are more psychoactive, psychological and social problems related to alcoholism and drug addiction than anything else which affect the individual and society emotionally.

    The following are the commonly abused groups of substances;

    • Alcohol
    • Cannabis
    • Cocaine
    • Nicotine
    • Opioids
    • Sedatives-hypnotics/anxiolytics

    Terms

    Drug (substance); this refers to any chemical agent that once taken in the body is capable of causing physiological and psychological changes.

    Alcoholic; this is a person who has been taking alcohol excessively in whom it has produced mental, social, physical and psychological problems

    Substance intoxication; this is development of a reversible substance-specific syndrome due to recent ingestion of or exposure to the drug

     Alcohol intoxication; a this is a temporally mental disturbance following heavy drinking so that the level of alcohol in blood is high and sufficient to affect somebody’s activity, mood and level of consciousness.

    Tolerance; this is a need for more of the drug in order to achieve a similar effect realised before at a lower dose

    Dependency; refers to compulsion to take the drug on a continuous basis in order to feel its effects and to further avoid the discomfort of its absence. This can both be physical or psychological. It is a bodily response to a substance e.g. relying on medications to control medical condition.

    Addiction; this refers to a psychological and physical inability to stop consuming a drug or substance even though it’s causing psychological and physical harm. it involves using the drugs despite the consequences.

    Misuse refers to the incorrect, excessive or non-therapeutic use of and mind-altering substances

    ALCOHOLISM

    Definition; alcoholism is a chronic condition occurring in individuals who have been taking alcohol excessively and for a long period of time that it has caused serious adverse effects physically, socially and mentally i.e. There is increased dependency of alcohol both physically and socially.

    Causes of alcohol abuse

    • Availability; if alcohol is available and drinking is accepted for example as a norm in social gatherings and functions
    • Genetic factors; some excessive drinkers have a family history of excessive drinking
    • Poor coping strategies; people who are unable to face stress often resort to alcoholism
    • Psychiatric disorders; like depressive disorders, anxiety disorders an phobic disorders
    • Social disorders; like isolation, unemployment, loss or bereavement, injustice etc.
    • High risk groups e.g. people suffering from chronic physical illness, business executives, travelling salespersons, industrial workers, hostel students, military personnel etc.
    • Age; its common between late adolescence and early adulthood

    Process of alcoholism

    1. Experimental; due to peer pressure, influences or curiosity, the person starts to consume alcohol
    2. Recreational; during weekends, or on holidays, the individual starts to enjoy and continue with it. If consumed in small quantities, alcohol may not cause a problem instead it may work to relieve tension and relax mind or sedate the brain from painful emotions and promote a sense of wellbeing and pleasure.
    3. Compulsive; once used to drinking, some people who started drinking occasionally start drinking almost daily or drinking heavily for a period of time for pleasure or to avoid the discomfort of withdrawal symptoms.

    Alcoholism goes through distinct stages;

    Early stage

    Increased tolerance– needing more and more of alcohol to experience the same pleasure as experienced earlier

    Blackouts- inability to recollect incidents which happened under the incidence of alcohol

    Preoccupation– always thinking about how, when and where to drink

    Middle stage

    Loss of control over amount, time and occasional drinking, Keeping away from alcohol for sometimes but going back to obsessive drinking after some period

    Chronic stage

    Getting drunk even on small amounts of alcohol, willing to lie, beg, borrow or steal to maintain supply of alcohol. Alcohol takes the priority over family or job.

    Types of drinkers

    Mild drinkers

    These rarely and occasionally drink alcohol in small amounts or in large amounts but once in a while and it rarely causes problems

    Moderate drinkers

    These moderately consume not in excess nor large amounts and it doesn’t cause much health problems

    Problem drinkers

    These consume large amounts of alcohol daily and usually with high concentrations. As a result, the individual health will be impaired, affects peace of mind, disrupts family, loss of reputation, dignity, poor performance etc.

    Effects and complications of alcohol

    Physical or medical effects
    • Hepatitis and liver cirrhosis
    • Pancreatitis
    • Peptic ulcers and gastritis
    • Cardiomyopathies and heart failure
    • Epileptic-like fits (RUM fits)
    • Tuberculosis
    • Weight loss
    • Alcoholic dementia
    • Anaemia
    • Malnutrition
    • Lowered immunity
    Psychiatric effects
    • Depression
    • Pathological intoxication such as maladaptive behavioural effects such as fighting, impaired judgement, slurred speech, mood changes, irritability and impaired attention
    • Delirium tremens
    • Alcoholic hallucinosis which are vivid hallucinations developing shortly after cessation or reduction of alcohol
    • Alcoholic psychosis this occurs after a person drinking alcohol for a long periods of time and in large quantities and thus develops psychotic disorder which resemble paranoid schizophrenia presenting with delusions, hallucinations and impairment of primary mental functions.
    • Alcohol amnestic disorder; there is impairment in short and long term memory with disorientation and confabulation
    • Alcoholic dementia; a chronic organic mental disorder that results into irreversible impairment in memory, orientation etc.
    • Suicide
    • Anxiety
    • Paranoia- persecutory and feelings of self-hate
    • Morbid or pathological jealousy e.g. a drunkard coming back at home and finds a ranch of a bicycle and begins quarrelling who has been at home
    • Hallucinations
    • Wernicke’s encephalopathy that occurs as a result of acute deficiency of vitamin B1 (Thiamine) in alcoholics
    • Korsakoff syndrome that occurs as a result of gradual depletion of thiamine from the body.
    Social problems
    • Decreased work performance hence decreased productivity due to chronic absenteeism
    • Family problems like divorce
    • Increased accidents due to drunken driving
    • Legal effects like rape, theft etc.
    • Violence and aggression

    Diagnosis of alcoholism

    1. History taking i.e. upbringing, family background, period taken while bussing etc.
    2. Clinical presentation like curly hair, swollen cheeks, red lips, poor hygiene etc.
    3. Using the questionnaire of CAGE

    C- Cut

    • Annoyed

    G- Guilty

    E- Eye opener

    The questionnaire looks as below;

    Have you ever felt that you should cut down your drinking?

    1. Yes
    2. No

    Have people annoyed you by criticizing your drinking?

    1. Yes
    2. No

    Have you ever felt guilty about your drinking?

    1. Yes
    2. No

    Have you ever had a drink as a first thing in the morning as eye opener to get rid of hangover or calm your nerves?

    1. Yes
    2. No

    Affirmative answers or any yes to two or more of the above is a suggestive to an alcoholic

    Concentration of alcohol in blood with their effects

    • 80-150mg of alcohol per 100mls of blood leads to intoxication
    • 150-300mg of alcohol per 100mls of blood is fatal
    • 300-500mg of alcohol per 100mls of blood is very fatal
    • 500mg of alcohol per 100mls of blood and above leads to death

    Note; all the above symptoms can change according to tolerance

    Management of alcoholism

    Aims

    The following are the major goals in the management of alcoholism;

    • To detoxify the patient (only in acute stages)
    • To improve social relationships and support
    • Developing confidence and ability to change
    • Identifying reasons to change
    • Developing alternative activities
    • Learning to prevent relapse

    Admission

    Admission is very essential to ensure that the patient doesn’t have access to alcohol. The patient has to be hospitalised and not allowed home for about 6-8 weeks since they have tremendous for alcohol and can soon start drinking if allowed home.

    • Admit the patient in a psychiatric hospital in an open quiet room which is well lit to reduce fears and illusions
    • Establish a good nurse patient relationship
    • Keep potentially harmful objects away from the room since there is chance of deliberate self-harm
    • Keep the bed dry, clean and warm since the patient might be incontinent
    • Monitor vital signs every 15 minutes initially including physical and mental behaviour
    • Investigations such as
    • Urine for sugar
    • Blood for haemoglobin level and sugars
    • Alcohol level in blood have to be carried out

    Medication

    • Administration of minor tranquilizers like anti-anxiety drugs such as Librium and diazepam are given parenterally if necessary to control anxiety, insomnia, agitation and tremors
    • Administer ant-convulsants if there is withdrawal seizure (rum fits)
    • Plenty of vitamins especially injection vitamin B1,B6 and B12 (100-300mg twice daily for seven days) and tablets of vitamin B complex and vitamin c
    • Antacids to relieve gastritis
    • Correct fluid and electrolyte imbalance by intravenous infusion and maintain a fluid balance chart
    • Drug Disulfiram (ant abuse therapy) which produces nausea and vomiting, intense headache, palpitation, blurred vision, hypotension and dyspnoea if alcohol is taken. It can be administered but under close patient supervision it is given 1g for one week then o.8g-0.6g-0.4g-0.2g and the patient is maintained on 0.1g for one year
    • Aversion therapy (Apo morphine) this is given in injectable form. It is a powerful emetic and the patient vomits whenever he smells alcohol. It is therefore discouraged for that
    • Yeast tablets are given two twice a day to induce appetite
    • Stamatil (avomine) is given 5-10mg to control vomiting
    • Sedation of the patient may be required
    • Avoid barbiturate drugs because alcoholics easily become addicted to them

    General nursing care

    • Physical and psychological conditions or mental conditions associated with advanced alcoholism should be treated like malnutrition, vitamin deficiencies, hallucinations, delirium, gastritis or liver diseases
    • Nutrition; Ensure that the patient takes small frequent feeding rather than large meals and the diet should be nutritious and appetising to enable the patient ask for more
    • Hygiene; oral care, general body and bed hygiene has to be addressed
    • During the recovery and rehabilitation period, acceptance of the patient by the nurse is essential. The nurse’s acceptance and may encourage the patient to socialise and participate in planned activities. This will also reduce the patient’s feelings of inferiority and low self-esteem.
    • Psychiatric social workers should be involved in the social problems of the patient
    • Religious commitment has to be encouraged
    • Familial therapy; these should be encouraged to help the patient to stay away from alcohol
    • Patient should be encouraged to change friends and associates may be necessary to remove patient from those situations where drinking is very easy
    • Prepare the patient for alcoholic anonymous a self-group of ex-addicts who confront, instruct and support fellow drinkers in their efforts to stay sober one day at a time, through fellowships and acceptance.
    • Plan for discharge and resettlement of the patient into the community

                    STEPS OF ALCOHOLIC ANONYMUS

    1. We admitted we were powerless over alcohol – that our lives had become unmanageable. AA firmly believes that individuals cannot overcome alcoholism on their own. They are unable to exercise willpower or personal strength that could prevent them from drinking
    2. Came to believe that a Power greater than ourselves could restore us to sanity. Alcoholics Anonymous is based on the belief in a higher power. For some, this higher power may be God; for others, it may be a belief in the universe itself. The point is that recovery begins, in part, by looking to an entity greater than yourself.
    3. Made a decision to turn our will and our lives over to the care of God as we understood Him.
    4. Made a searching and fearless moral inventory of ourselves. During this step, many participants make a list of poor decisions or character flaws. They outline hurt they caused to others, as well as feelings, like fear and guilt, that motivated some of their past actions. Once the individual has acknowledged these issues, the issues are less likely to serve as triggers to future alcohol abuse.
    1. Admitted to God, to ourselves and to another human being the exact nature of our wrongs. As AA members work this step, they sit down with someone – often their sponsor – and confess everything they identified in Step 4. This step requires the recovering individual to put aside their ego and pride to acknowledge shameful past behavior. The step is also empowering, as the alcoholic no longer has to hide behind guilt and lies.
    1. Were entirely ready to have God remove all these defects of character. In this step, the recovering alcoholic acknowledges that he or she is ready to have a higher power – again, whatever that may be – take away the moral shortcomings identified in
    1. Humbly asked Him to remove our shortcomings. This step requires the person to focus on the positive aspects of his or her character – humility, kindness, compassion and a desire for change – as well as step away from the negative defects that have been identified.
    1. Made a list of all persons we had harmed, and became willing to make amends to them all. During this step, recovering alcoholics write down a list of all the people they have hurt. Often, this list includes people they hurt during their active alcoholism; however, it may go back further to include anyone they have hurt throughout their entire lives
    1. Made direct amends to such people wherever possible, except when to do so would injure them or others. Paired with Step 8, Step 9 gives recovering alcoholics the opportunity to make things right with those they have hurt. One’s sponsor can be a big source of help during this process, helping the recovering alcoholic to determine the best way to go about making amends.
    1. Continued to take personal inventory and when we were wrong promptly admitted it. Linked to Step 4, this step involves a commitment to continue to keep an eye out for any defects of character. It also involves a commitment to readily admit when one is wrong, reinforcing humility and honesty.
    1. Sought through prayer and meditation to improve our conscious contact with God as we understood Him, praying only for knowledge of His will for us and the power to carry that out. Step 11 commits the recovering alcoholic to continued spiritual progress. For some, this may mean reading scripture every morning. For others, it may mean a daily meditation practice. Alcoholics Anonymous doesn’t have stringent rules on what form spiritual growth takes. It simply involves a commitment to take time to reassess one’s spiritual and mental state.
    1. Having had a spiritual awakening as the result of these steps, we tried to carry this message to alcoholics and to practice these principles in all our affairs practice these principles in all our affairs. The final step involves helping others and serves as motivation for many to become sponsors themselves. By going through the 12 steps, individuals have a major internal shift and part of that shift is a desire to help others.

    Nurses role in the prevention of alcohol abuse

    Primary prevention

    Aim to avoid the appearance of new cases of alcohol abuse by reducing alcohol consumption through health promotion especially health education

    Secondary prevention

    Attempt to detect cases early and to treat them before serious complications cause disability

    Tertiary prevention

    Aim to avoid further disabilities and to reintegrate individuals into the society who have been harmed by severe alcohol related problems

    The nurse will be involved in all of these levels

    Substance Abuse Read More »

    Narcotics

    Narcotics

    Narcotics

    Narcotics or Narcotic drugs are drugs that react with different type of opioid receptors, receptor sites that respond to naturally occurring peptides, enkephalins, and endorphins.

    These are found in the CNS, peripheral nerves, and GI tract cells.

    In the spinal cord, they integrate and relate pain information. Pain relief and side effects depend on the type of receptor site.

    Pain

    Pain is mostly a subjective experience of unpleasant sensation and emotional experience. People respond to pain differently because of cultural differences, learned experiences, and environmental stimuli.

    A-delta and C-fibers are two sensory nerves that respond to stimulation by generating nerve impulses that produce pain sensations.

    Classification of pain

    Pain Classification According to Duration:

    1. Acute Pain – is caused by tissue It is the type of pain which makes the person aware of the injury and leads him to seek for care and education about the injury and how to take care for it.
    2. Chronic Pain – is a constant or intermittent pain that keeps occurring long past the time the area would be expected to This is the type that can interfere with activities of daily living.

    Pain Classification According to Source

    1. Nociceptive Pain – caused by direct pain receptor stimulus
    2. Neuropathic Pain – caused by nerve injury
    3. Psychogenic Pain – associated with emotional, psychological, or behavioral stimuli

    Types of opioid receptors

    1. Mu-receptors – primarily pain-blocking receptors; also account for respiratory depression, euphoria, and development of physical
    2. Beta-receptors – modulate pain transmission by reacting with enkephalins in the periphery
    3. Kappa-receptors – associated with some analgesia, pupillary constriction, sedation, and dysphoria
    4. Sigma-receptors – pupillary dilation, hallucinations, psychoses with narcotic use.

    Types of narcotic drugs

    Narcotics are divided into 3 classes;

    1. Narcotic Agonists – react with opioid receptors in the CNS; cause analgesia, sedation, or They are classified as controlled substances because they have potential for physical dependence.
    2. Narcotic Agonists-Antagonists – stimulate certain opioid receptors but block other such They exert similar analgesic effect with that of morphine but they have less potential for abuse. However, they are associated with more psychotic like reactions.
    3. Narcotic Antagonists – bind strongly to opioid receptors without causing receptor activation. They block opioid receptor effects as well as effects of too much opioids in the system.

    Narcotic Agonists

    These drugs react with opioid receptors in the CNS; cause analgesia, sedation, or euphoria.

    Therapeutic Action

    The desired and beneficial action of narcotic agonist is:

    • Narcotic agonists act as agonist to specific opioid receptors in the CNS to produce analgesia, euphoria, and sedation.

    Indications

    Narcotic agonists are indicated for the following medical conditions:

    1. Relief of moderate to severe acute pain or chronic pain
    2. Preoperative medication
    3. Component of combination therapy for severe chronic pain
    4. Intra-spinal to reduce intractable

    Indication of narcotic agonists in different age groups

    Children

      1. Safety and effectiveness has not been established in
      2. Narcotic agonists that have established pediatric dosage guidelines are codeine, fentanyl (except transdermal), hydrocodone, meperidine, and morphine
      3. Naloxone is the antidote for narcotic overdose and reversal of narcotic

    Adults

    1. They should be informed and reassured that associated abuse with the use of narcotics in acute pain is remote.
    2. They should be educated about the importance of asking for pain medication before the pain becomes acute.
    3. Caution is advised for pregnant and lactating women because of potential adverse effects to the fetus.
    4. Narcotics used in labor include morphine, meperidine, and oxymorphone.
    5. All narcotic agonists are pregnancy category B except oxycodone (category C) so it might be the drug of choice if one is needed during pregnancy.

    Older adults

    1. They are more susceptible to drug adverse effects because of existing medical conditions.
    2. Safety measures should be established (side rails, call light, assistance to ambulate).

    Contraindications and Cautions

    The following are contraindications and cautions for the use of narcotic agonists:

    1. Allergy to narcotic agonists. Prevent hypersensitivity reaction
    2.  Diarrhea caused by toxic poisons. Drug depresses GI activity and this could lead to increased absorption and toxicity
    3.  Respiratory dysfunction. Exacerbated by respiratory depression caused by drugs
    4. Recent GI/GU surgery, acute abdomen, ulcerative colitis. Can be worsen by the GI depressive effects of the narcotics
    5.  Head injuries, alcoholism, delirium tremens, cerebral vascular disease. Can be exacerbated by
      the CNS effects of the drug
    6.  Liver, renal dysfunction. Can interfere with metabolism and excretion of the drug
    7.  Pregnancy, lactation. Potential adverse effects to the fetus and the baby.

    Adverse Effects

    Use of narcotic agonists may result to these adverse effects:

    1. CNS: light-headedness, dizziness, psychoses, anxiety, fear, hallucinations, pupil constriction, impaired mental processes
    2. GI: nausea, vomiting, constipation, biliary spasm
    3. GU: ureteral spasm, urinary retention, hesitancy, loss of libido
    4. Others: sweating, physical and psychological dependence
    5. Narcotic-induced respiratory center depression: respiratory depression with apnea, cardiac arrest, shock

    Interactions

    The following are drug-drug interactions involved in the use of narcotic agonists:

    1. Barbiturates, phenothiazines, MAOIs: increased likelihood of respiratory depression, hypotension, and sedation or coma
    2. SSRI, MAOI, TCA, Johns Wort: increased risk of potentially life-threatening serotonin syndrome if taken with tapentadol, the newest narcotic agonists that blocks norepinephrine reuptake in the CNS
    3. Methylnaltrexone bromide (Relistor) is the treatment for opioid-induced constipation in palliative care patients who are no longer responding to traditional laxatives.

    Drugs used as narcotic agonists

    Drug

    Indications

    Dosage ranges

    Key issues to note

    Codeine

    Analgesic, antitussive

    Relief of pain

    Adult: 30-60mg every 4-6 hours when necessary max dose 240mg daily.

    Children: 1-12years: 0.5-1 mg/kg every 4-6hours

    Diarrhoea

    Adults: 30mg 3-4 times daily

    1.  Increase fluids and fibre intake to avoid constipation

    2.  Avoid alcohol during therapy with codeine

    3.  Avoid abrupt discontinuation after prolonged use

    4.  Codeine is not recommended for treatment of productive cough

    5.  Codeine may be administered with food to minimise nausea

    and GI upset

    Pethidine

    1.  Pre-operative medication

    2.  Acute analgesia

    3.  Post-operative pain

    4.  Moderate to severe acute pain Obstetric analgesia

    Acute pain

    Adult: SC or 1M injection; 50- 150mg repeated after 4 hours Children: O.5-2mg/kg every 4 hours

    Obstetric analgesia: SC or 1M injection, 50-100mg repeated 1- 3 hours later if necessary max dose is 400mg in a day

    Post-operative pain: SC/IM

    injection

    1.  Prolonged use of Pethidine may result in physical dependence

    2.  Lowest effective doses are recommended especially during

    labor

     
      

     

      

    Adult: 25-100mg repeated every 2-3 hours if necessary

    Children: 0.5-2mg/kg every 2 to

    3 hours

     

    Oxycodone

    Analgesic

    Oxycodone: 10–20 mg

    PO q12h; 5 mg for break thru pain

     

    Other narcotic agonist analgesic drugs

    1. Methadone
    2. Oxymorphone
    3. Propoxyphene
    4. Fentanyl

    Short notes about Morphine

    Morphine is the ‘gold standard’ against which other opioid analgesics are measured.

    When used correctly, patients don’t become dependent, tolerance is uncommon and respiratory depression doesn’t usually occur.

    The correct morphine dose is the one that gives pain relief: there is no ‘ceiling’ or maximum dose — the right dose is the one that controls the patient’s pain without side effects, however you need to increase the dose gradually.

    Dosage of morphine

    Morphine has no ceiling effect to the analgesia.

    There is no standard dose of morphine for the treatment of chronic pain in patients with cancer and HIV/AIDS.

    It must be individually titrated for each patient and the correct dose is that which controls the pain whilst causing tolerable side effects.

    The dose required depends on many factors including the severity of pain, the type of pain, individual pharmacokinetic variations, the development of tolerance., and the psychosocial issues that affect the perception of pain.

    Acute pain, postoperative pain:

    • Oral: 5-20mg every 4 hours

    By SIC or 1M injection

    • Adult: 10 mg every 4 hours if necessary
    • Neonate: 150mcg 1kg every 6hours
    • 6-12 years: 5-10mg every 4 hours
    • 1-5years: 2.5-5mg every 4 hours
    • 1 month -12months: 200mcg/kg every 6hours

    Chronic pain: Oral ISC or 1M:

    • Adult: 10-15mg every 4 hours. Dose may be increased according to the response
    • Children: 2-12years: Initially 200-500mcg/kg every 4hours adjusted according to response
    • 1-2years: Initially 200-400mcg/kg every 4hours adjusted according to response
    • 1-12months: Initially 80mcg/kg every 4hours

    Myocardial infarction:

    • By slow IV injection (2mg/ minute), 10mg followed by a further 5-10mg if necessary.
    • Elderly or debilitated patients, give a half a dose

    Acute pulmonary oedema:

    • By slow IV injection (2mg/minute) 5-10mg

    Action of morphine

    Morphine acts on the opioid receptors in the brain and spinal cord to produce analgesia.

    The perception of pain is altered both by a direct effect on the spinal cord, modulating peripheral nociceptive input, arid by activating the descending inhibitory systems from the brain stem and basal ganglia.

    Morphine also acts on the limbic system and on higher centers to modify the emotional response to pain.

    The system effects, including those affecting the gastrointestinal and respiratory tracts, arc partly centrally mediated via the autonomic nervous system and may partly be due to a direct effect on opioid receptors in the peripheral tissues.

    Indications

    1. Post-operative pain
    2. Myocardial infarction
    3. Premedication before surgery
    4. Severe pain
    5. Sickle cell crisis
    6. Acute pulmonary oedema
    7. Chronic pain (cancer)

    Common Side effects

    The common side effects of morphine include:

    1.  Constipation — therefore you should always give a laxative alongside morphine (unless the individual has diarrhoea) e.g. Bisacodyl 5mg at night increasing the dose to l5mg if needed.
    2.  Nausea and vomiting — if this occurs, give anti-emetics e.g. plasil 10mg 8 hourly.
    3.  Drowsiness — may occur in the first few days of taking morphine. If it does not improve after three days reduce the dose of morphine.
    4.  Itching — not very common but if it occurs reduce the dose of morphine

    Contraindication

    1. Morphine should be given with caution to patients with renal impairment, severe hepatic dysfunction, significant pulmonary disease (including acute or severe bronchial asthma), and CNS depression from any cause.
    2. Elderly patients and those who are debilitated or cachectic should initially be treated with reduced doses.

    Dose

    Titrating oral Morphine into other formulations

    • Titrate the regular dose of morphine over several days until the patient is pain free. Either add the total daily dose and the total breakthrough dose given in 24 hours and divide by six to get the new 4hrly dose, or give 30—50% increments, e.g. 5—10—15mg etc., given as 4hrly doses. Increments of less than 30% are ineffective.
    • If the patient cannot swallow, use other routes, e.g. Rectal, subcutaneous, buccal, intravenous, or administer via an alternative enteral route such as a gastrostomy tube.
    • The ratio of morphine PO: SC is 2:1, g. 10mg oral morphine is 5mg SC morphine.
    • The ratio of morphine PO:IV is 2—3:1, g. 30mg oral morphine is 10mg IV morphine
    • Morphine is available in immediate and slow-release oral Use slow- release morphine once pain is controlled, dividing the total 24-hour dose into two to get the twice-daily dosage.

    Useful tips when using morphine

    1.  Oral morphine can be absorbed through the mucosa of the buccal cavity (mouth) or of rectum, so small amounts can be given even for unconscious patients.

    2.  Even though a patient is on regular oral morphine they may have breakthrough pain, an additional dose of oral morphine may be given to control this pain. This may be a one off incidence of pain but if more frequent breakthrough doses are required this may mean the 4hourly dose needs increasing.

    3.  Pain has to be controlled before other problems can be addressed and treated, as it is not possible to have meaningful discussions about psychosocial concerns if a patient has
      uncontrolled pain

    4.  Pain can be caused or aggravated by psychosocial concerns, which must be addressed before good pain control can be achieved. Where psychosocial or spiritual problems are causing or
      aggravating pain, no amount of well-prescribed analgesia will relieve the pain until the responsible psychosocial issues are identified and addressed.

    5.  Oral morphine is effective for chronic severe pain and can be given for many years and the dose can keep increasing, some patients can even take up to several hundred mgs 4 hourly.

    6.  If the pain stimulus is removed, then the dose of morphine should be decreased gradually to minimize the effects of physical dependence.

    7.  Opiates can also be used as a short term analgesia: in AIDS opportunistic infections such as
      cryptococcal meningitis; sickle cell crisis; burns and other painful conditions and does not cause
      addiction

    Narcotic Agonists-Antagonists

    These drugs stimulate certain opioid receptors but block other such receptors.

    Therapeutic Action

    The desired and beneficial action of narcotic agonist-antagonist is:

    • Narcotic agonists-antagonists act on certain opioid receptors but block other such receptors. They have less potential for abuse compared to narcotic agonists but are able to exert similar analgesic effect as morphine.

    Indications

    Narcotic agonists-antagonists are indicated for the following medical conditions:

    1. Relief of moderate to severe pain; pre-anesthetic medication and a supplement to surgical anesthesia
    2.  May be desirable for relieving chronic pain in patients who are susceptible to narcotic dependence.

    Here are some important aspects to remember for indication of narcotic agonist-antagonists in different age groups:

    Children

    • Safety and effectiveness has not been established in children.
    • Narcotic agonist-antagonist of choice for children older than age 13 is buprenorphine.
    • Naloxone is the antidote for narcotic overdose and reversal of narcotic effects..

    Adults

    • They should be informed and reassured that associated abuse with the use of narcotics in acute pain is remote.
    • They should be educated about the importance of asking for pain medication before the pain becomes acute.
    • Caution is advised for pregnant and lactating women because of potential adverse effects to the fetus.

    Older adults

    • They are more susceptible to drug adverse effects because of existing medical conditions.
    • Safety measures should be established (side rails, call light, assistance to ambulate).

    Contraindications and Cautions

    The following are contraindications and cautions for the use of narcotic agonists-antagonists:

    1. Allergy to narcotic agonists-antagonists. Prevent hypersensitivity reaction
    2. Physical dependence on narcotics. Withdrawal symptom may be precipitated
    3. COPD, other respiratory dysfunction. Can be exacerbated by respiratory depression
    4. MI, CAD, hypertension. Can be exacerbated by cardiac stimulatory effects
    5. Renal, hepatic dysfunction. Interfere with drug metabolism and excretion
    6. Pregnancy, lactation. Potential adverse effects to the fetus and the baby.
    7. Nalbuphine is specifically contraindicated to patients who are also allergic to sulfites to prevent cross-hypersensitivity reactions.

    Interactions

    The following are drug-drug interactions involved in the use of narcotic agonist-antagonists:

    1. Barbiturates, phenothiazines,    MAOIs:    increased    likelihood    of    respiratory depression, hypotension, and sedation or coma
    2. Tripelennamine: increased hallucinogenic and euphoric effect with pentazocine (“Ts and Blues”)
    3. Methylnaltrexone bromide (Relistor) is the treatment for opioid-induced constipation in palliative care patients who are no longer responding to traditional laxatives.

    Types of drugs used as narcotic agonists antagonist

    Drug

    Indications

    Dosage ranges

    Nalbuphine

    Analgesia

    10 mg/70 kg SC, IM,

    IV q3–6h PRN

    Pentazocine

    Analgesia

    50–100 mg PO q3–4h PRN; up to

    30 mg IM, SC, IV q3–4h PRN

    Pentazocine

    Analgesia

    1 tablet q4h

     

    Nursing Considerations when administering narcotic agonists and narcotic agonist-antagonists

    Nursing Assessment

    These are the important things the nurse should include in conducting assessment, history taking, and examination:

    1. Assess for mentioned cautions and contraindications (e.g. drug allergy, respiratory dysfunction, myocardial infarction and CAD, hepatorenal dysfunction, ) to prevent untoward complications.
    2. Conduct pain assessment with patient to establish baseline and evaluate effectiveness of drug therapy.
    3. Perform thorough physical (CNS, vital signs, bowel sounds, urine output) to establish baseline status before beginning therapy, determine drug effectiveness and evaluate for any potential adverse effects.
    4. Monitor laboratory results (liver function, kidney function) to determine need for possible dose adjustment and identify toxic drug effects.

    Nursing Diagnoses

    Here are some of the nursing diagnoses that can be formulated in the use of these drugs for therapy:

    1. Impaired gas exchange related to respiratory depression
    2. Disturbed sensory perception related to CNS effects
    3. Constipation related to GI effects
    4. Risk for injury related to CNS effects

    Implementation with Rationale

    These are vital nursing interventions done in patients who are taking narcotic agonists and narcotic agonists-antagonists:

    1.  Perform baseline and periodic pain assessments with patient to monitor drug effectiveness and provide appropriate changes in pain management protocol as needed.
    2.  Have a narcotic antagonist and equipment for assisted ventilation readily available when administering this drug IV to provide patient support in case of severe reaction.
    3.  Monitor timing of analgesic doses. Prompt administration may provide a more acceptable level of analgesia and lead to a quicker resolution of the pain.
    4.  Provide non-pharmacological pain measures like breathing exercises, back rubs, and stress reduction to increase drug effectiveness and reduce pain.
    5.  Provide comfort measures (e.g. small, frequent meals for GI upset) to help patient tolerate drug effects.
    6.  Provide safety measures (e.g. adequate lighting, raised side rails, etc.) to prevent injuries.
    7.  Educate client on drug therapy to promote understanding and compliance.

    Evaluation

    Here are aspects of care that should be evaluated to determine effectiveness of drug therapy:

    1. Monitor patient response to therapy (relief of pain, sedation).
    2. Monitor for adverse effects (e.g. GI depression, respiratory depression, arrhythmias, etc).
    3. Evaluate patient understanding on drug therapy by asking patient to name the drug, its indication, and adverse effects to watch for.
    4. Monitor patient compliance to drug therapy.

    Narcotic Antagonists

    They bind strongly to opioid receptors without causing receptor activation. They block opioid receptor effects as well as effects of too much opioids in the system

    Therapeutic Action

    The desired and beneficial action of narcotic antagonists is as follows:

    • Narcotic antagonists are drugs that bind strongly to opioid receptors but do not activate them. They block the opioid receptors and reverse the effects of opioids like respiratory depression and sedation.

    Indications

    Narcotic antagonists are indicated for the following medical conditions:

    1. Indicated for complete or partial reversal of narcotic depression; diagnosis of suspected opioid

    Indication of narcotic antagonists in different age groups:

    Children

    1.  Safety and effectiveness has not been established in children.
    2.  Naloxone is the antidote for narcotic overdose and reversal of narcotic effects.

    Adults

    1. They should be informed and reassured that associated abuse with the use of narcotics in acute pain is remote.
    2. They should be educated about the importance of asking for pain medication before the pain becomes acute.
    3. Caution is advised for pregnant and lactating women because of potential adverse effects to the fetus and the baby.

    Older adults

    1. They are more susceptible to drug adverse effects because of existing medical conditions.
    2. Safety measures should be established (side rails, call light, assistance to ambulate).

    Contraindications and Cautions

    The following are contraindications and cautions for the use of narcotic antagonists:

    1.  Allergy to narcotic antagonists. Prevent hypersensitivity reaction
    2.  Pregnancy, lactation. Potential adverse effects to the fetus and the baby.
    3.  Narcotic addiction. Precipitation of a withdrawal symptom
    4.  CV disease. Exacerbated by the reversal of the depressive effects of narcotics

    Adverse Effects

    Use of narcotic antagonists may result to these adverse effects:

    1. CNS: excitement, reversal of analgesia
    2. CV: tachycardia, blood pressure changes, dysrhythmias, pulmonary edema
    3. Acute narcotic abstinence syndrome: nausea, vomiting, sweating, tachycardia, hypertension, tremulousness, feelings of anxiety. A naloxone challenge should be administered before giving naltrexone to help to avoid acute reactions.

    Interactions

    There is no significant drug-drug interactions involved with narcotic antagonists.

    Types of drugs used as narcotic antagonists

    Drug

    Indications

    Dosage ranges

    Nalmefene

    Complete or partial reversal of opioid effects

    Initial dose: 0.5 mg /170 kg IV PRN, second dose of 1 mg170 kg 2-5 min

    later; maximum dose, 1.5 mg /170 kg

    Naltrexone

    Narcotic overdose. postoperative narcotic

    depression

    0.4-2 mg IV initially with additional doses repeated at 2-3 min intervals; smaller doses used for post-

    operative narcotic depression

    Pentazocine

    Narcotic addiction. alcohol dependence

    Maintenance treatment: 50 mg PO daily or 100 mg every other day, or 150 mg PO every third day; 2 mL IV,

    SC

     

    Nursing Considerations

    Nursing Assessment

    These are the important things the nurse should include in conducting assessment, history taking, and examination:

    1. Assess for mentioned cautions and contraindications (e.g. drug allergy, history of narcotic addiction, myocardial infarction, ) to prevent untoward complications.
    2. Conduct pain assessment with patient to establish baseline and evaluate effectiveness of drug therapy.
    3. Perform thorough physical (neurological status, respiratory rate and rhythm, vital signs) to establish baseline status before beginning therapy, determine drug effectiveness and evaluate for any potential adverse effects.
    4. Obtain an electrocardiogram as appropriate to evaluate for cardiac effects.

    Nursing Diagnoses

    Here are some of the nursing diagnoses that can be formulated in the use of this drug for therapy:

    1. Decreased cardiac output related to CV effects
    2. Acute pain related to withdrawal and CV effects
    3. Risk for injury related to CNS effects

    Implementation with Rationale

    These are vital nursing interventions done in patients who are taking narcotic antagonists:

    1. Maintain open airway and provide artificial ventilation and cardiac massage as needed to support the patient.
    2. Administer vasopressors as ordered and as needed to manage narcotic overdose.
    3. Administer naloxone challenge before giving naltrexone because of the serious risk of acute withdraw.
    4. Provide comfort measures to help patient cope with withdrawal syndrome.
    5. Provide safety measures (e.g. adequate lighting, raised side rails, ) to prevent injuries.
    6. Ensure that patients receiving naltrexone have been narcotic-free for 7-10 days to prevent severe withdrawal syndrome.
    7. Educate client on drug therapy to promote understanding and compliance.

    Evaluation

    Here are aspects of care that should be evaluated to determine effectiveness of drug therapy:

    1. Monitor patient response to therapy (reversal of opioid effects, treatment of alcohol dependence).
    2. Monitor for adverse effects (e.g. CV changes, arrhythmias, hypertension, etc).
    3. Evaluate patient understanding on drug therapy by asking patient to name the drug, its indication, and adverse effects to watch for.
    4. Monitor patient compliance to drug therapy.

    Opioid infusion administration considerations

    1. Unless the patient has received a recent dose of opioid, a loading dose should be administered (according to the EPIC prescription) at the commencement of the infusion to ensure therapeutic plasma levels are quickly reached.
    2. For rapid relief of pain (or anticipated pain), the prescribed bolus dose should be reached.
    3. The infusion rate may be adjusted by the nurse within the dose range specified, according to the patient’s level of pain.
    4. It takes approximately four half-lives (8hrs for morphine/hydromorphone, ~1.5hrs for fentanyl) to reach steady state plasma concentration if given as an infusion, therefore if the rate is to be increased, a bolus should be given as well.
    5. Ideally the infusion rate should not be increased unless 3 boluses are required in a 1 hour period.
    6. The volume infused should be checked every hour and rate verified on the fluid balance flow chart.

    Narcotics Read More »

    Post-traumatic stress disorder (PTSD)

    Post-traumatic stress disorder (PTSD)

    Post-traumatic stress disorder (PTSD)

    Post-traumatic stress disorder (PTSD) is an anxiety disorder characterized hyper-arousal, re-experiencing of images of the stressful events and avoidance of reminders.

    >  It is a disorder that develops after a person sees, is involved in or hears
    (experiences) of an extreme traumatic stressor.
    >   Is a condition occurring when an individual experiences extreme rare stressful event, the person reacts with severe anxiety, feeling of numbing and avoidance of thinking about the events which is often interrupted at times by sudden vivid and distressing recall of these events.
    >  It is a mental health disorder associated with torture.

    PTSD may be immediate response to the stressor or may follow an interval of days or occasionally months. It usually improves within months, but may persist for years.
    Post Traumatic Stress Disorder was first recognized in 1980 by American Psychiatric Association (APA). Before, it was known as:-

    •  Shell shock
    • Soldiers’ heart
    • Rape trauma syndrome
    • Concentration camp syndrome.

    Aetiology

    1.  An exceptionally stressful event in which the person was involved in directly or as a witness.
    Examples of stressful events.

    •  Wars
    • Floods
    • Earthquakes
    • Gang rape
    • Terrorism
    • Accidents
    • Fire out break

    2.  However there is a variation in responses depending on personal vulnerability.
    3.  Genes was found to be part of the vulnerability by twin studies.
    4. Other predisposing factors. For example:

    •  Uncontrolled temperament.
    • Age: children and old people are more vulnerable.
    • Gender: women are more vulnerable
    • History of psychiatric disorders
    • Previous traumatic experiences including separation from the parents and child abuse.
    • Differences in a way threatening events are appraised and encoded in the brain.

    5.  Neuroendocrine factors which include: sensitization of noradrenergic system.
    Sensitization of serotonergic system. Reduction in cortisol levels.
    6. Psychological factors:

    •  Fear conditioning. Classical conditioning may be involved.
    •  Cognitive theory: PTSD arises when the normal processing of emotionally charged information is over whelmed, so that memories persist in an unprocessed form in which they can intrude into the conscious awareness.
    •  Psychodynamic theory: emphasizes the role of the previous experience in determining the individual variations in response to severely stressful events.

    7. Maintaining factors:

    •   Negative appraisal of early symptoms
    •  Avoidance of reminders which prevents deconditioning and cognitive reappraisal.
    •  Suppression of anxious thoughts.

    Diagnostic criteria signs/ symptoms

    1. The child has been exposed to a very traumatic event outside the usual range of human experience and would be frightening to any one.

    •  Could be the subject of trauma
    • Could be the perpetrator of the trauma.
    • Could be a mere observer.

    2. Persistent re-experiencing of traumatic event.

    •  Recurrent and intrusive recollections of the events. (In young children, repetitive play may occur in which themes or aspects of trauma are expressed).
    • Recurrent distressing dreams of events. (A child may have frightening dreams without recognizable content).
    • Acting or feeling as if the traumatic event were recurring. (Trauma specific re-enactment may occur)
    • Experience intense psychological distress at exposure to events that symbolize or resemble the traumatic event).

    3. Persistent avoidance of stimuli associated with trauma

    •  Efforts to avoid thought or feeling associated with trauma.
    • Avoiding activities or situations resembling the trauma.
    • In ability to recall important aspects of trauma.
    • Diminished interest in activities.
    • Feeling of detachment from others.
    • Restricted range of affect.
    • Sense of foreshortened future.

    4. Persistent symptoms of increased arousal

    •  Difficult in falling or staying asleep.
    • Irritability or out burst of anger.
    • Difficulty in concentrating.
    • Hyper-vigilance – not settled.
    • Exaggerated startle response.
    • Physiological reactivity upon exposure to events symbolizes or resembles the trauma.

    5. Symptoms for at least one month.
    If symptoms last for:-

    •  Less than 3 months – acute PTSD
    • More than 3 months – chronic PTSD
    • Begin 6 months after the stressor- delayed PTSD.

    Summary of symptoms of PTSD

    The principle symptoms of post traumatic stress disorder includes;
    Hyper-arousal

    •  Persistent anxiety
    •  Irritability
    •  Insomnia
    •  Poor concentration.

    Intrusions

    •  Difficulty in recalling stressful events at will.
    •  Intense intrusive imagery (flash back).
    • Recurrent distressing dreams.

    Avoidance

    •  Avoidance of reminders of the vents
    • Detachment
    • Inability to feel emotion (numbness).
    • Diminished interest in activity.

    Reactions

    •  Night mares
    • Terrifying dreams
    • Vivid recall of the events (images)
    • Depression/ sadness
    • Irritable
    • Anxiety
    • Anti-social behaviors.

    Management of PTSD

    Treatment usually involves psychotherapy and counseling, medication, or a combination.

    Assessment
    Assess the following;

    •  Nature and severity of the stressful event
    • The nature and duration of the symptoms
    • Previous psychiatric history
    • Previous personality
    • Neurological examination should be done to exclude a subdural haematoma or other forms of cerebral injury. If the event included injury like from assault or accident.

    Treatment
    1. Early treatment

    •  If the response is not severe, sympathetic support and help with practical problems subsequent to disaster may suffice.
    • Counseling provides emotional support and discourages recall.
    • Facilitates working through the associated emotions.
    • Few doses of anxiolytic drugs may be needed to calm the person.
    • The person is helped to talk about and reconsider the event and express feelings about them. This may need to be done repeatedly.

    2. Chronic PTSD is difficult to treat.

    •  It requires series of interview where by the person is encouraged to recall, re-experience and work through the emotions associated with the event.
    • Cognitive therapy or techniques have been used to desensitize patients to reminders and images of the stressful events.

    Options for psychotherapy will be specially tailored for managing trauma.

    3. Cognitive processing therapy (CPT): Also known as cognitive restructuring, the patient is taught to think about things in a new way. Mental imagery of the traumatic event may help them work through the trauma, to gain control of the fear and distress.

    4. Exposure therapy: Talking repeatedly about the event or confronting the cause of the fear in a safe and controlled environment may help the person feel they have more control over their thoughts and feelings.

    5. Medications

    Some medications can be used to treat the symptoms of PTSD.

    • Selective serotonin reuptake inhibitors (SSRIs), such as paroxetine, are commonly used. SSRIs also help treat depression, anxiety and sleep problems, symptoms that are often linked to PTSD. 
    • benzodiazepines may be used to treat irritability, insomnia, and anxiety. However, the National Center for PTSD do not recommend these, because they do not treat the core symptoms and they can lead to dependency.
    •  anxiolytics should be avoided unless other wise because of dependence after prolonged use. Antidepressants may be used in low doses for example fluoxetine could be given.

    The patient has to be taught about the following self help techniques

    Active coping is a key part of recovery. It enables a person to accept the impact of the event they have experienced, and take action to improve their situation.

    • learning about PTSD and understanding that an ongoing response is normal and that recovery takes time
    • accepting that healing does not necessarily mean forgetting, but gradually feeling less bothered by the symptoms and having confidence in the ability to cope with the bad memories

    Other things that can help include:                          

    • finding someone to confide in
    • spending time with other people who know what happened
    • letting people know what might trigger symptoms
    • breaking down tasks into smaller parts, to make them easier to prioritize and complete
    • doing some physical exercise, such as swimming, walking ETC.
    • practicing relaxation, breathing, or meditation techniques
    • listening to quiet music or spending time in nature
    • understanding that it will take time for symptoms to go away
    • accepting that PTSD is not a sign of weakness but can happen to anyone
    • participating in enjoyable activities that can provide distraction

    Post-traumatic stress disorder (PTSD) Read More »

    antipsychotics

    ATYPICAL ANTIPSYCHOTIC

    Atypical or second generation or novel 

    Atypical or ‘2nd generation’. These medications have been used since the 1990s. These are newer types of antipsychotics.

    • These are sometimes referred to as ‘atypicals’

    These are newer antipsychotic drugs on the Ugandan market and are less commonly used because they are  expensive. They are however the best antipsychotics because they control both negative and positive  symptoms of schizophrenia. These drugs are also associated with fewer side effects compared to the  typical antipsychotics. Are also called new antipsychotic drugs.

    • Some are also less likely to cause sexual side effects compared to first generation antipsychotics.

    But second generation antipsychotics may be more likely to cause serious metabolic side effects. This may include rapid weight gain and changes to blood sugar levels, diabetes mellitus, hypercholesterolemia.

    Mechanism of Action 

    • They block 5-HT2A-receptors with lesser degree of antagonism of D2-receptor. 
    •  Have efficacy against negative effects especially clozapine 
    •  As a result, they have fewer extrapyramidal adverse effects than the older traditional agents.
    • Atypical agents are serotonin-dopamine 2 antagonists (SDAS)
    • They are considered atypical in the way they affect dopamine and serotonin neurotransmission in the four key dopamine path way in the brain.

    Classes of Atypical Antipsychotics

    •  Benzoxazoles- Risperidone 
    • Dibenzodiazepines – Clozapine  
    •  Thienobenzodiazepine- Olanzapine  
    •  Dibenzothiazepine- Quetiapine   
    •  Imidazolidinone – Sertindole 

    Risperidone (Risperdal)

    • Available in regular tabs, I.M depot form and rapidly dissolving tablet.
    • Functions more like atypical antipsychotic at doses greater than 6 mg.
    • Increased extra pyramidal side effects (dose dependent) 
    • Most likely atypical to induce hyperprolactinemia. 
    • Weight gain and sedation (dose dependent) 
    • Hypotension, fatigue, abdominal pain, nausea.

    Olanzapine (Zyprexa)

    • Available in regular tabs, immediate release I.M, rapidly dissolving tab, depot form. Dose 5mg-20mg/ day-OD /nocte.

    Side effects

    • Sedation, weight gain, hypotension, anti cholinergic effects, changes in liver function tests.

    Quetiapine (Seroquel)

    • Available in a regular tablet form only.
    • Dose: 100-400mg bid or DDD

    Side effects

    • Weight gain,
    • Most likely to cause orthostatic hypotension 
    • Increase blood sugar-diabetes     

    Clozapine (Clozaril) 

    Available in one form-a regular tablet

    • Dose: 100-900mg bid or in  DDD

    Side effects

    • Sedation , weight gain 
    • Hyper salivation

    SIDE EFFECTS OF ANTI-PSYCHOTICS:

    Extra pyramidal side effects:

    Most of the anti-psychotic drugs may cause the imbalance of the neurotransmitters (excitatory and inhibitory) resulting into side effects known as extra pyramidal.

    1. Acute dystonia– uncontrolled muscular spasm. Muscle from spasm many part of the body, for example:
    • Oculogyric: crisis-eyes rolling upwards. 
    • Torticollis: head and neck twisted to the side

    The patient may be unable to swallow or speak clearly. in extreme cases , the back may arch or the jaw dislocate.

    Management: 

    • Give artane tablets or anticholinergic drugs given orally, I.M or I.V depending on the severity of symptoms.
    • Benzodiazepines like diazepam.
    • Some times change in medication, or lowering dose.
    1. Parkinsonian symptoms (pseudo-parkinsonism)
    • Tremor
    • Rigidity 
    • Bradykinesia: decreased facial expression, flat monotone voice, slow body movements, inability to initiate movement.
    • Mask like face
    • Bradyphrenia
    • Slowed thinking 
    • Salivation
    • Drooping posture.

    Management 

    • Reduce the antipsychotic dose.
    • Change to atypical drug (as antipsychotic monotherapy)
    • Prescribe an anticholinergic like Artane.
    1. Akathisia (restlessness) A subjectively unpleasant state of inner restlessness where there is a strong desire or compulsion to move.
    • Foot stamping when seated.
    • Constantly crossing or uncrossing legs.
    • Rocking from foot to foot.
    • Constantly pacing up and down.

    Management

    • Reduce or lower the antipsychotic dose.
    • Give benzodiazepines like diazepam
    • Give beta blockers like propranolol 
    • Give an anti cholinergic like artane.
    1. Tardive dyskinesia (abnormal movement): It is an irreversible extrapyramidal syndrome usually common in patients who have been on anti-psychotics for long. It is characterized by persistent involuntary movement of all oral facial muscles.
    • Rabbit syndrome: lip smacking or chewing type movement as of a rabbit.
    • Tongue protrusion: fly catching.
    • Choreiform hand movements (pill rolling or piano playing)

    Severe orofacial movement can lead to difficulty, speaking, eating, or breathing. Movements are worse when under stress.

    Management:

    • Stop anti-cholinergic if prescribed
    • Reduce dose of anti psychotic.
    • Change to a typical drug.
    1. Neuroleptic malignant syndrome: It is rare but fatal (life threatening), occurs as a result of prolonged intake of anti psychotic drugs it is characterized by:
    • Severe mental, motor and autonomic disturbance.
    • Hyper tonicity increased muscle tone. There is an increased reflex to stimuli.
    • Generalized stiffness of the muscles affecting i.e. patient may find it unable to swallow.
    • Hyperpyrexia increased body temperature, because of that, they get profuse  sweating, this leads to fast dehydration
    •  There is increased blood pressure leading to tachycardia.

    The mortality rate is 20 % as per global population. They need intensive medical and nursing.

    For the above extra-pyramidal side effects, we use the following drugs to counter act them.

    • Benzhexol (artane)

    We can use 2mg-4mg o.d /bid 4-5 days and then go back to PRN when acute. But otherwise, they are supposed to be given when necessary. It is under the group of anti-cholinergic drugs under the classification of drugs.

    • Benztropine mosylate (congetin)

    It also falls under the group of anti-cholinergic.

    Dose: 0.5-1mg to 4mg maximum o.d / PRN (orally) 

    Injection: 1mg-2mg to I.m-PRN.

    N.B: Children below 5yrs should not be given chlorpromazine (Largactil). Use haloperidol.

    Other side effects as per systems.

    Gastro intestinal tract(GIT)

    •  Dry mouth: Management: Rinsing of mouth with water (avoid candy ‘’sweetie’’ as carriers may result).
    •  Excessive salvation (sialorrhea): management give antiparkinsonian like artane or stop drug.
    •  Constipation: management: give high fibred diet, laxatives like bisacodyl
    •  Sedation: management: give smaller dose in the morning some patients can only cope with single night-time dosing. Reduce dose if necessary. 

    Cardio vascular system:

    •  Postural hypotension (orthostatic hypotension): Management: advise patient to take time when standing up or change posture gradually. Reduce dose or slow down rate of increase 
    •  Cardiac arrhythmias (ECG changes): Management:  ECG monitoring, change drug.

    Endocrine and metabolic system:

    •  Weight gain: Management: dietary control, exercise, change drug.
    • Galactorrhea (increased lactation): Management: change the drug
    • Amenorrhea: Management: change the drug.
    • Decreased libido: Management: reduce dose or change drug.

    Haemotological.

    • Bone marrow depression.
    • Obstructive jaundice.

    Ocular 

    • Blurred vision 
    • Glaucoma- increased intraocular pressure
    • Retina  pigmentation (may lead to blindness)

    Genital and urinary systems.

    • Retention of urine-people can retain or pass urine 
    • Polyuria- excessive passage of urine of low specific gravity.
    • Impotence.

    Allergic.

    • Photo sensitivity.
    • Skin pigmentation.
    •  Nasal congestion (thioridazine)

    NURSE’S RESPONSIBILITY FOR A PATIENT RECEIVING ANTIPSYCHOTICS

    • Instruct patients the patient to take sips of water frequently to relieve dryness of mouth. Frequent mouth washes, use of chewing gum, applying glycerine on the lips are also helpful.
    • A higher fiber diet, increased fluid intake and laxatives if needed, help to reduce constipation.
    • Advise the patient to get up from the bed or chair slowly. Patient should sit on the edge of the bed for one full minute dangling his feet before standing up. Check BP before and after medication is given. This is an important measure to measure to prevent falls and other complications resulting from orthostatic hypotension.
    • Differentiate between akathisia and agitation and inform the physician. A change of drug may be necessary if side effects are severe. Administer antiparkinsonian drugs as prescribed
    • Observe the patient regularly for abnormal movements
    • Take all seizure precautions.
    • Patient should be warned about driving a car or operating machinery when first treated with antipsychotics. Giving the entire dose at bedtime usually eliminates any problem from sedation.
    • Advise the patient to use sunscreen measures (use of full sleeves, dark glasses etc) for photosensitive reactions.
    • Teach the importance of drug compliance, side-effects of drugs and reporting if too severe, and regular follow ups. Give reassurance and reduce unfounded fears and anxieties.
    • Seizure precautions should also be taken as clozapine reduces seizure threshold. The dose should be regulated carefully and the patient may also be put on anticonvulsants such as carbamazepine.

    ATYPICAL ANTIPSYCHOTIC Read More »

    Want notes in PDF? Join our classes!!

    Send us a message on WhatsApp
    0726113908

    Scroll to Top
    Enable Notifications OK No thanks